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EmrE is a small multidrug resistance transporter in E. coli. It effluxes a wide range of antibiotics, 
thus contributing to the evolving epidemic of drug resistance. Despite its small size, EmrE is a 
fully functional transporter making it an ideal model system for a comprehensive study of the 
multidrug transport mechanism. In the transport cycle, EmrE must alternate between outward- 
and inward-facing conformations upon substrate binding to translocate substrates across the 
membrane. High-resolution structures of EmrE in complex with substrates facing different sides 
of the membrane will shed light on the coupling mechanism between substrate binding and 
transport. However, the conformational plasticity that enables EmrE to transport diverse drugs 
also makes it a very challenging system for high-resolution structural studies. The 
conformational dynamics inherent in the transport process require experimental measures of 
structural transitions to provide the link between static structures and functional transport. This 
thesis aims to characterize the structure and dynamics of EmrE in atomic detail using NMR, a 
well-established technique to study structure and dynamics of biomolecules simultaneously 
under a variety of conditions.  
xii 
 
In the case of EmrE, NMR spectroscopy is the best approach for high-resolution structures 
because the dynamic nature and small size of EmrE hamper X-ray crystallography and cryoEM 
approaches. I have made significant progress towards a better structure of EmrE using a slow-
dynamics mutant and have achieved a near complete backbone and side chain ILV methyl 
assignment for this highly challenging helical membrane protein system. I have also collected a 
large data set of distance and orientational restraints. I have also used NMR and functional 
assays to characterize a series of mutants located near the transmembrane helix 3 (TM3) kink 
and have demonstrated the important role of TM3 kink formation for the global conformational 
interconversion required for alternating-access. My NMR data also suggest that hydration within 
the transport pore may be an important property fine-tuning the rates of conformational 
interconversion. My NMR pH titrations show that the slow-dynamics mutant also has elevated 
pKa values for E14, the critical residue for proton-coupling in EmrE. This provides the first 
experimental evidence of the physicochemical link between proton and substrate binding and 
alternating-access necessary for achieving coupled transport. By correlating high-resolution 
structural and dynamic data with functional transport assays, this thesis provides key insights 
into the multidrug transport mechanism of EmrE. The principles learned for EmrE set the stage 




Chapter 1: Introduction 
 “If we were to name the most powerful assumption of all, which leads one on and on in an 
attempt to understand life, it is that all things are made of atoms, and that everything that living 
things do can be understood in terms of jigglings and wigglings of atoms.” 
--- Richard Feynman, The Feynman Lectures on Physics 
One of the emerging principles in biochemistry and molecular biology is that the functions of 
biological molecules is ultimately rooted in the physical motions of atoms composing these 
molecules
1
. Understanding the nature of these motions at different time and length scales is 
deeply linked to comprehending molecular mechanisms. With the great success of structural 
biology in the past decades, we now have the luxury of researching biology at the atomic level. 
To move beyond structure-function relationships and construct the new paradigm: structure-
dynamics-function, both spatial and temporal resolutions are essential. Despite recent exciting 
progress in biophysical techniques, e.g. spectroscopy and modeling, the field of biomolecular 
dynamics remains immature due to the limitations of current theories, the tremendous technical 
difficulties, and the challenging interpretations of dynamic information from measured physical 
properties. 
In my doctoral thesis, I focus on a small multidrug resistance transporter, EmrE, to study its 
structure and dynamics by using NMR spectroscopy and other biophysical techniques in order to 
understand the multidrug transport mechanism. Hopefully the knowledge gained will ultimately 




Structure-dynamics-function: the new paradigm 
Structural biology has played an instrumental role in modern biology. It has generated beautiful 
structures for many biomolecules, which have greatly advanced our understandings of cellular 
processes and facilitated the development of modern medicine
2
. By solving structures of 
biomolecules, one is provided the opportunity to explain sometimes puzzling phenomena and 
generate structure-based hypotheses to guide future experiments. This type of structure-function 
relationship study is widely acknowledged for its usefulness. The most famous case of using 
structure to gain mechanistic insight is the structure of DNA double helix
3
 which immediately 
suggests the semiconservative replication mechanism
4
 by which DNA is replicated in all known 
cells, one of the most fundamental questions in biology. Even today, it is common a new 
structure may provide novel insight into questions accumulated over 20 years of biochemistry. 
However, life is in motion. These static structures can also be deceptive when they subtly 
suggest that these molecules are solid rocks, albeit with complicated texture. In fact, biological 
molecules are defined as soft materials in physics since they can be easily deformed by thermal 
energy at room temperature. These molecules are not static at all; they sample ensembles of 
conformations with only some captured in structural biology research. To truly understand the 
workings of biomolecules it is important to capture different conformational states. Although 
more difficult, understanding how biomolecules transition between different conformational 
states is also important since the different modes that a specific molecule samples are subjected 
to evolution along with the structures. With this concept in mind, biomolecules should better be 




There are already exciting studies on biomolecular dynamics, which signal the importance of this 
field. For example, systematic studies of the whole catalytic cycle of DHFR have identified key 
substates along with characterization of interconversion rates between different substates
5-7
. 
Armed with these beautiful structures, populations (thermodynamics), and rates of 
interconversion (kinetics), a movie can be constructed to watch biomolecules work in action! 
Another example where protein dynamics play a key role is allosteric signaling. Since proteins 
exist in an ensemble of conformations, large scale domain motions provide the physical basis for 
signal transduction through protein-protein interactions in the nanoscale
8
. In the case of RNA, 
which is known to be highly dynamic and whose dynamics are encoded by intrinsic properties of 
RNA structures and external environmental factors, it is not surprising to learn that RNA 
molecules can both carry genetic information and perform a wide variety of functions
9
. Even for 
DNA, they can sample many more conformations than simply being just straight double helices 
as generally assumed
10,11
. The emerging theme for biomolecules is that much of the functional 
complexity lies not only in the intricate details of the 3D structures but also in their ability to 
sample distinct conformations.  
 
Transporters are inherently dynamic. 
Most progress in the field of protein dynamics has occurred in studies of soluble proteins. 
Despite the key role of membrane proteins in controlling the information and material flow 
between cells and the environment and their importance as drug targets, membrane protein 
dynamics research is limited. This is in part because it is still technically challenging to work 
with membrane proteins. Due to the hydrophobic nature, membrane proteins need to be purified 
in a solubilizing environment, e.g. in detergent, which should maintain their native states. A 
4 
 
great deal of trial-and-error is still needed to screen for conditions that can generate useful 
research materials in the first place. Only in the last decade has structural biology of membrane 
proteins exploded. Exciting new structures of membrane receptors, ion channels, and transporters 
are being published, which is paving the way for dynamic studies to provide the next level of 
insights into understandings of mechanism and function of these important biomolecules. 
Membrane transporters are an important family of membrane proteins that are inherently 
dynamic. As membranes are needed so life forms can separate self from environment, this 
necessitates biological machineries that reside in the membrane to relay signals and selectively 
import nutrients and export wastes. As a result, there are many membrane transporters in cells to 
move molecules in and out, and malfunctions of transporters are implicated in various 
diseases
12,13
. Membrane transporters, like enzymes, are inherently dynamic entities as required 
by their functions. In order to transport substrates across the membrane, transporters need to bind 
substrates and switch between at least two conformations, one outward-facing and one inward-
facing. So in the case of transporters, the linkage between structure and dynamics is critical for 
proper function. They cannot be completely understood solely on the basis of static structures, 
even if these structures are of high resolution. Therefore, membrane transporters are an exciting 
new frontier to study structure-dynamics-function relationships. 
 
Alternating access in transport 
Initial attempts to understand transport processes proposed a “moving carrier” model
14
. In this 
model, carriers bind substrates and then move across the membrane before releasing the 
substrates on the other side. Now, we know that the moving carrier model may account for 
5 
 
transport processes carried out by ionophores like valinomycin. But for protein transporters 
which are integral membrane proteins, our current understandings of membrane and protein 
structures suggest that such a model would have energetic barriers that are prohibitively high.  
Our mechanistic understandings of transport cycles now are defined by the alternating access 
model. In this model, transporters have at least two conformations, one outward-facing and one 
inward-facing, and alternate between these two conformations to expose the substrate binding 
site to one side of the membrane and then the other
15-18
. In the presence of transporters, the 
permeability barrier for substrates imposed by the membrane is no longer fixed. Instead, as the 
transporter alternates conformations, the permeability barrier moves shifting to the closed side of 
the transporter. As a result, the alternating access model was also called the “moving barrier” 
model in early literature. This model has been so successful to describe biochemical observations 
of transport processes that it dominates the field today.  
The alternating access model is conceptually compelling and useful since diverse transport 
processes can be categorized based on minor modifications of the basic concept involved. 
Transport processes can be divided into active transport and passive transport (known as 
facilitated diffusion) based on whether an energy source is needed or not. In facilitated diffusion, 
no energy is consumed and thus the direction of transport is always down the concentration 
gradient of the transported substrate(s). Uniporters are involved in facilitated diffusion. To 
complete the transport cycle, uniporters will need to alternate the binding site from one side of 
membrane to the other both in the presence and absence of substrates. One example of uniporters 






In active transport, substrates are transported against their concentration gradients using some 
source of energy. In primary active transport, as in the large family of ABC transporters, ATP 
molecules are consumed to fuel the conformational changes required for the alternating access 
and to drive substrates against their concentration gradients. Thus metabolic energy stored in 
ATP is transformed into the chemical potential of the transported substrates. Secondary active 
transport, also known as cotransport or coupled transport, instead relies on the energy stored in 





, is used to fuel the “uphill” movement of another substrate. Secondary active 
transporters can be further classified into symporters and antiporters, depending on whether the 
transported substrates move in the same or opposite directions (Fig. 1.1). In symport, both 
substrates cross the membrane in the same direction. Mechanistically, symport is explained 
through alternating access of the substrate-binding site on the transporters only when either all 
coupled substrates are bound or when the binding site is empty. The alternating access of the 
binding site cannot happen when only one substrate is present; otherwise the cotransport would 
be decoupled. In contrast, in antiport, the substrates move across the membrane in opposite 
directions, and the coupling is traditionally explained by (i) requiring strict competition between 
the substrates for a single binding site so only one substrate can bind at a time and (ii) allowing 





Fig. 1.1 Secondary active transporters can be classified into symporters (A) and antiporters (B). The transporters are 
represented in green and two different substrates are represented as a yellow sphere and a lavender hexagon.  
 
In the alternating access model, the conformational interconversion, during which transporters 
switch between outward-facing and inward-facing conformations, is central to the transport cycle. 
It is at this step that transporters reorient substrate binding sites from facing one side of 





Understanding how the binding of substrates to transporters is linked to transport is deeply 
related to understanding how the conformational interconversion occurs at an atomic level.  
As a result of the large scale conformational changes involved in the conformational 
interconversion process, the movement of substrates across the membrane by transporters is 
much slower compared to channels. Ion movements through channels can be as fast as diffusion 
since channels can be viewed as holes in the membrane that have complex regulations of their 
opening and closing. The topological constraints set by transporters in active transport are 
necessary for them to transport substrates against their concentration gradients using an energy 
source. This could never be realized by a pore-like structure as in channels.   
As discussed, the transport process is an inherently dynamic process. In this thesis, I focused on 
the conformational interconversion process in transport, in the hope of providing deeper 
understanding of the physical basis of the transport mechanism.  
 
EmrE: a model system 
EmrE is a small multidrug resistance transporter in E. coli that utilizes the proton-motive force 
across the inner membrane to efflux polyaromatic cationic antibiotics. Due to its small size, 
EmrE has been extensively studied as a model system for membrane protein folding and 
insertion
22
, membrane protein topology
23,24
, membrane protein evolution
25,26
, and proton-coupled 
antiport
27
.  In addition, it is implicated in bacterial antibiotic resistance and biofilm formation
28,29
, 
making it potentially clinically relevant as well. Yet, after more than 20 years of studies using a 
variety of methods ranging from molecular biology to biophysics, our mechanistic understanding 





One example of how this seemingly “simple” model system turns out to be rather complicated is 
illustrated in the controversy related to the structure and topology of EmrE
27,31
. The sequence of 
EmrE has 110 amino acids, and the hydropathy analysis of EmrE immediately (and correctly) 
suggested four transmembrane helices
32
. However, it took several lines of studies to establish 
that the functional unit of EmrE is an antiparallel dimer
33-37
. Looking back, several layers of 
complexity made the topology of EmrE controversial for a long time. In essence, all the major 
obstacles are a result of our rather primitive understandings about membrane proteins. The first 
major obstacle lies in the biochemistry involved in purifying EmrE. Earlier studies of EmrE used 
organic solvents which are now known to disrupt the native state of EmrE as manifested in a 
weaker affinity to TPP
+38,39
, a commonly used EmrE ligand. Also some bulky tags used for 
purification of recombinant EmrE turned out to affect the membrane insertion and topology
25,40
, 
further complicating data interpretation. Finally, EmrE is among the earliest examples of dual 
topology, where a membrane protein with no particular charge bias in the loop regions can insert 
into membrane without preference of a particular orientation. This was totally unexpected given 
the understanding of membrane protein synthesis and insertion at the time and led to great 







Fig. 1.2 Available experimental structures for TPP
+
-bound EmrE. A. A cryoEM electron density map from 2D 
crystallography (7.5 Å resolution) at a contour level of 59.7. Image from EMDataBank (EMD-1087). EmE was 
purified in DDM and crystallized in DMPC bilayers. B. A model based on cryoEM map and evolutionary 
conservation. Image from PDB (2I68). TPP
+
 is not shown. C. The X-ray crystal structure (PDB: 3B5D). Image from 
Chen et al., 2007. EmrE was purified and crystallized in N-nonyl-β-D-glucoside (NG). To properly reflect the low-
resolution nature, only Cα atoms were deposited. D. Ribbon representation of the EmrE-TPP
+
 X-ray structure 
docked into the EM density map, contoured at 1.2 σ. The TM helices are labeled and the two monomers are 
distinguished by asterisks. Image from Chen et al., 2007. 
 





 studies (Fig. 1.2), although both are of moderate resolution. The cryoEM structure of EmrE 
in complex with TPP
+
 showed for the first time that the functional unit of EmrE is an asymmetric 
dimer with six transmembrane helices forming the ligand binding chamber
37
. This discovery was 
independently supported by X-ray structures from another group
34
. Follow-up studies from the 
11 
 
Tate group in collaboration with Nir Ben-Tal
33
 considering the evolutionary conservation of each 
helix and the pseudo two-fold symmetry between the two monomers insightfully proposed that 
the antiparallel dimer could switch between outward- and inward-facing conformations if the two 
monomers simply swap conformations. This predicts the two structures of EmrE open to 
opposite sides of the membrane are structurally the same. Immediately, this model could 
reconcile the structural asymmetry in the dimer with functional symmetry suggested by bulk 
biochemical data. Further dynamics studies (Fig. 1.3) using high-resolution solution NMR, 
single-molecule FRET, and cross-linking studies lent overriding support for this elegant model
35
. 
Additional in vivo experiments confirmed the antiparallel dimer topology in the native E. coli 
environment
36,42




These structures are instrumental to establish the topology of EmrE. However, due to the 
moderate resolution and the dynamic nature of EmrE, only Cα atoms coordinates were deposited 
for both the cryoEM and X-ray structures. How is the TPP
+
 ligand coordinated in the binding 
pocket? How could substrates binding lead to the conformational interconversion that lies at the 
heart of energetic coupling? In order to progress towards answering these mechanistic questions, 




Fig. 1.3 Conformational interconversion in EmrE. A. Conformational interconversion for antiparallel, asymmetric 
EmrE: the two monomers swap conformations and the outward- and inward-facing states have identical structures 
except for which aqueous compartment is accessible to the transport pore. The two structures are related by a 180˚ 
rotation about an axis that is parallel to the bilayer and perpendicular to the page. The measured interconversion rate, 
kconf, is ~5 s
-1
 at 45˚C. B. Chemical shift difference between the two monomer conformations plotted onto the 
antiparallel dimer model (left) or an overlay of the two monomers with transmembrane helices 1-3 aligned to 
compare the two monomers within the antiparallel dimer (right). Figure from Morrsion et al., 2012. 
 
 
NMR is an ideal tool for determining a better structure of 
EmrE. 
High-resolution structures of transporters facing either side of the membrane provide a great deal 
of insights into the transport mechanism. These structures will directly reveal how substrates are 
coordinated in the binding pocket, and which interactions need to be disrupted in inward-facing 
conformation and then rebuilt in outward-facing conformation as the transporter interconverts 
13 
 
between states. Such high-resolution structures of transporters in different states are challenging 
to obtain. Our previous NMR studies revealed that drug-bound EmrE has the same structure in 
outward- and inward-facing conformations. So by determining the structure of drug-bound EmrE, 
we can get both outward- and inward-facing states. This structure will identify substrate 
coordinating interactions and shed light on the coupling mechanism between substrate binding 
and conformational exchange. This long-sought high-resolution structure of EmrE will serve a 
defining role in integrating all the available data to understand the mechanism and guide future 
experimental design in the field. 
However, the conformational plasticity that enables EmrE to transport diverse drugs also makes 
it a very challenging system for high-resolution structural studies. This dynamic nature of EmrE 
and lack of soluble domains hamper the formation of well-packed crystals for X-ray and also 
prevents high-resolution structure determination by cryoEM. The same considerations lead to the 
failure of alternative methods for crystalizing membrane proteins by inserting soluble domains or 
using crystallization antibodies. Thus, NMR spectroscopy is the best approach for EmrE 
structure determination. Structure determination by NMR is one major area of research (and Kurt 
Wuthrich was awarded the 2002 Nobel chemistry prize for developing NMR techniques for 
structure determination of biomolecules). However, although NMR can accommodate some 
dynamics, it needs a relatively static structure for NOE measurement (long mixing time). 
Inspired by the success of thermal stabilization by point mutations in GPCR crystallography
43,44
, 
we collaborated with Chris Tate at Cambridge to screen and select EmrE mutants with preserved 




NMR provides a dynamic description of the EmrE 
alternating access process. 
As transport is inherently a dynamic process, a dynamic view is needed to provide a necessary 
link between static structures and functional transport. NMR spectroscopy is a well-established 
technique to study protein structure and dynamics simultaneously under a variety of conditions. 
In fact, the most unparalleled application of NMR is its power to study dynamics.  
There are a collection of NMR dynamics experiments to study motions at different timescales 
(Fig. 1.4). The dynamic information provided by these experiments is derived from relaxation 
time measurements
45,46
. In NMR, relaxation means the return of a spin system to its equilibrium 
following a perturbation. The rate of return depends on the time-dependent magnetic fields the 
spin is experiencing. Since local magnetic field fluctuates as a result of molecular motions, the 
relaxation of spin systems can be linked to dynamic information.  
Macromolecules typically tumble in the nanosecond timescale, so motions that are much faster 
or slower than tumbling time can be detected. Motions faster than nanosecond timescale are 








N NOE experiments. Motions in the microsecond-
to-millisecond timescale could be studied using T1ρ and CPMG experiments while motions in the 







Fig. 1.4 Protein dynamics and NMR dynamics experiments. A. Free energy as a function of an arbitrary 
conformational coordinate. The free energy landscapes of proteins are very rugged with multiple minima. 
Fluctuations between different local minima have barriers of varying heights that translate into a wide range of 
timescales. B. Typical timescale ranges for different types of protein motions. C. NMR experiments that can be used 
to study dynamics on different timescales. Figure adapted from Ferella, et al. 2012. 
 
Chemical shift is one very sensitive NMR observable that could report on dynamics of molecules. 
When a nucleus is exposed to different chemical environments as the molecule samples different 
conformations, chemical shifts of that nucleus in the resulting NMR spectrum could provide 
information about both population (thermodynamics) and exchange rates (kinetics). Based on 
comparisons between exchange rates and chemical shift differences, this is usually divided into 
slow-exchange regime, intermediate-exchange regime, and fast-exchange regime. The resulting 




Fig. 1.5 The time regime of chemical exchange in NMR is defined by the relative magnitudes of kex and Δν. The 
effects of varying kex are demonstrated on the one-dimensional NMR spectra with PA = 75%, PB = 25%, and Δν = 
100 Hz. In the slow exchange regime (kex << Δν = ΔωAB/2π), two separate peaks are observed for the two states 
reflecting their distinct chemical shifts, intensities, and linewidths. In the fast exchange regime (kex >> Δν = 
ΔωAB/2π), only one signal is observed with population-weighted averages of chemical shift, intensities, and 
linewidths. At intermediate exchange regimes, the linewidth is increased due to exchange broadening. Figure from 
Ferella, et al. 2012. 
 
Our dynamics studies of EmrE focus on the conformational interconversion process, which 
occurs in the millisecond-second timescale. So ZZ-exchange experiments are the main dynamics 
experiment used to characterize different mutants of EmrE and EmrE with different substrates. 
ZZ-exchange is used to characterize the kinetics of interconversion between different 
conformational states in the slow exchange regime
48
. It is based on multidimensional chemical 
shift correlation experiments with the addition of a mixing time between indirect and direct 
17 
 
dimension frequency detection. During the mixing time, the magnetization is aligned along the Z 
axis, parallel to the magnetic field. If conformational exchange happens during the mixing time, 
there will be additional cross-peaks from exchange in the spectrum. The kinetic exchange rates 
could be extracted by recording a series of ZZ-exchange experiments with varying mixing time. 
Homonuclear NOESY experiment could be seen as the simplest ZZ-exchange experiment, and 








N spin pair exchanging between two 
states. ZZ-exchange is useful for studying dynamics in the slow exchange regime where state A (red) and B (blue) 
give rise to separate peaks in NMR spectra. During the mixing time T, magnetization is aligned along the Z-axis, 
parallel to the static magnetic field. When T = 0, this experiment gives rise to two auto-peaks at (ωN,A, ωH,A) and 
(ωN,B, ωH,B) for the two states. When T is long enough for measurable exchange to occur, A to B and B to A 
conversions during the mixing time lead to two additional cross-peaks (magenta) at (ωN,A, ωH,B) and  (ωN,B, ωH,A). 





Molecular dynamics (MD) simulation is another major technique that can reveal a great deal of 
dynamic information about biomolecules. These “computational microscopes”
49
 could deliver 
unparallelled all-atom descriptions about the dynamics of biomolecules. However, these 
simulations are based on imperfect force fields, and the timescale involved here is several orders 
of magnitude longer than could be afforded by currently available computing resources. So a 
combination of both experiment and modeling is needed. Through collaboration with the lab of 
Emad Tajkorshid (University of Illinois at Urbana-Champaign), we have also integrated 
molecular modeling and molecular dynamics (MD) simulations to complement our solution 
NMR studies of EmrE structure and dynamics. 
 
Scope of Thesis 
This thesis uses mainly solution NMR to characterize the structure and dynamics of EmrE in 
atomic detail. Chapter 2 summarizes efforts to identify and characterize EmrE dynamics mutants 
suitable for structure determination. Chapter 3 describes efforts toward a high-resolution 
structure of EmrE in complex with drug using solution NMR spectroscopy. Chapter 4 
investigates a series of mutants with different ligands to elucidate the role of helix kinking in 
conformational interconversion. Chapter 5 reports the asymmetric features of the EmrE C-
termini that have largely been overlooked to date. By correlating high-resolution structural and 
dynamic data with data from functional transport assays, this thesis investigates the multidrug 
transport mechanism of EmrE. The new insights enrich our understanding of the key properties 
controlling proton-driven drug efflux in EmrE and set the stage for understanding even more 
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Chapter 2: Search for putative dynamics 
mutants 
Introduction 
The transport cycle of a transporter requires several structural states. EmrE is a proton-coupled 
antiporter; therefore, there are at least three structural states in terms of ligand binding: drug-
bound, proton-bound, and the true apo state. In our structural studies of EmrE, we focus on the 
drug-bound state. This drug-bound state is the most studied; and there are two low-resolution 
structures available
1,2
, significantly lowering barriers involved in solving a membrane protein 
structure using NMR. Also, with the drug occupying the binding site, there is reduced amide 
exchange
3
 useful for long NMR experiments. For the ligand we focus on TPP
+
, which is the 
mostly commonly used ligand for EmrE. The affinity of EmrE for TPP
+
 is in the nanomolar-to-
micromolar range
4
, making a fully ligand-saturated state easy to achieve. This avoids potential 
complications from ligand binding equilibrium with a low-affinity binder.  
The constant conformational interconversion of EmrE poses a significant challenge for NMR 
structure determination of EmrE. This is a problem for any NMR experiments long enough to 
allow cross-peaks from conformational interconversion to build up. For example, NOESY 
experiments, to measure NOEs, the major class of structural restraints, necessitate the use of 
really long mixing times (up to a few hundred milliseconds). But for TPP
+
-bound WT EmrE, the 
interconversion rate is ~5 s
-1
 in our NMR conditions
4
. Thus, cross-peaks from conformational 
interconversion build up long before NOEs peaks appear, seriously complicating data 
interpretation. This was experimentally verified
4
 – exchange cross-peaks were visible with 
NOESY mixing times as short as 25 ms for TPP
+
-bound WT EmrE at pH 7, and mixing times 
26 
 
long enough to measure NOEs resulted in identical NOE observations for both monomers due to 
the extensive exchange occurring during the mixing time effectively averaging the two states. 
Inspired by the success of thermal stabilization by point mutations in GPCR crystallography
5,6
, 
we collaborated with the lab of Chris Tate (MRC Laboratory of Molecular Biology, Cambridge, 
UK) to screen and select for putative dynamics mutants of EmrE. The Tate lab constructed a 
library of EmrE mutants containing V, A, or G at each position and then screened these mutants 








. Mutants that displayed good ligand 
binding but loss of function were selected with hope that these mutants would reflect loss of 
dynamics.  
I went on to further characterize these putative dynamics mutants identified in the screen. I used 
an in-cell drug export assay
9
 to evaluate the ethidium bromide export capabilities of cells 
expressing EmrE mutants. This assay provides a more nuanced readout on mutant transport 
activity by monitoring the kinetics of ethidium efflux over short periods of time, whereas 
dilution plating simply reflects whether drug efflux is sufficient to enable survival over 24 hours. 
For mutants that indeed have impaired drug export, I then purified isotopically labeled protein to 
record NMR TROSY-HSQC spectra. The ideal mutants suitable for structural studies should 
maintain the overall asymmetric dimer peak pattern with favorable lineshape properties, 
reflecting a stable and properly folded structure. I then performed ZZ-exchange experiments to 
quantify the conformational interconversion rates
4
. I wanted mutants that have slower 
interconversion rates than WT EmrE, since our initial goal was structure determination. I also 







Materials and methods 
Sample preparation WT and mutant EmrE was expressed, purified, and reconstituted into 
DLPC/DHPC isotropic bicelles as previously described
4,9,10
. Single point mutants were 
constructed using QuickChange (Stratagene). 
In-cell assay These assays were carried out using the BL21(DE3) strains of E. coli transformed 
with empty pET15b vectors or pET15b-EmrE. The cells were grown in M9 minimal media with 
100 μg/ml of ampicillin at 37 ˚C until the OD600 reached 0.4. Then cells were induced with 0.33 
mM isopropyl 1-thio-β-D-galactopyranoside (IPTG) at the same temperature for 30 minutes 
followed by incubation with 2.5 μM ethidium bromide and 40 μM carbonyl cyanide p-
chlorophenylhydrazone (CCCP) for an hour to load ethidium bromide into the cells. The cell 
cultures were then stored on ice until assays were complete. For each experiment, 2 ml of cell 
culture was spun down and immediately resuspended in 1 ml fresh M9 media with 2.5 μM 
ethidium bromide. Fluorescence of ethidium bromide was monitored with an excitation 
wavelength at 545 nm and emission wavelength at 610 nm. The time course of fluorescence was 
plotted after normalization to the initial value of each run. 





in 20 mM potassium phosphate, 20 mM NaCl, 8-10% D2O, pH 7 at 45 ˚C on a Varian 700 MHz 
spectrometer with a room temperature probe. For TPP
+
-bound EmrE, 1-2 mM TPP
+
 was added 




N TROSY-HSQC and TROSY-selected ZZ-exchange experiments
11
 
with a lipid flip-back pulse
4
 were carried out with a recycle delay of 2 s and 128-144 increments. 





 using the composite peak ratio method with an 11.1 ms time offset to 
account for the back-transfer time in the pulse sequence
9
. All NMR spectra were processed with 
NMRPipe
13
 and analyzed in CcpNmr Analysis
14
. 
Isothermal titration calorimetry All isothermal titration calorimetry (ITC) experiments were 
performed with EmrE reconstituted into DLPC/DHPC (q = 0.33) isotropic bicelles in 20 mM 
potassium phosphate, 20 mM NaCl, pH 7, 45 ºC. All ITC experiments were performed on a TA 
instruments LV Nano calorimeter. Data were fit simultaneously to a model of ligand binding to n 





Results and discussion 
Putative dynamics mutants from screening Chris Tate’s lab identified  and provided us with the 
first batch of seven putative dynamics mutants from the comprehensive screening (Table 2.1): 
M21G, A59L, S64V, G90V, I101G, N102A, and N102V.  
 
Figure 2.1 Locations of putative dynamics mutations in the secondary structure (left) and in monomer A of the X-
ray structure (right). The secondary structure figure was adapted from Elbaz et al., 2008. Glycine residues are 




The locations of these seven residues (Fig. 2.1) can be categorized into three regions that may be 
important in conformational interconversion. Residue M21 lies at the end of TM1, with one M21 
at the bottom of the binding pocket while the other is above the binding pocket due to the 
asymmetric dimer architecture of EmrE. This residue is located in the same TM helix as E14, the 




 TM3 kink region, 
which is important for conformation interconversion and multidrug recognition from cryoEM 
and NMR studies
1,4,9,15,16
. Like M21, A59 lies at one end of a TM helix where it transitions into 
the loop region. G90, I101, and N102 are located in TM4, the dimerization domain of EmrE
17,18
. 
In TM4 of EmrE, there is a knobs-into-holes motif where glycine residues (90/97) from one 
monomer pack against Leu/Ile residues (93/94) from the other monomer. 
 
Table 2.1 Growth phenotype summary from dilution plate assays for V/A/G mutants of EmrE. Residues 
in each transmembrane helix (TM) are labeled with the helix number in the TM column. Three different 
substrates and two different concentrations (low and high) of drug substrates were screened: methyl 
viologen (50 and 200 μM), acriflavine (116 and 463 μM), and ethidium bromide (EtBr, 400 and 1500 μM). 
Symbols: ++, similar to WT EmrE; +, growth on higher concentrations of substrates, but weak; +/-
, only growth on lower concentration; -, no growth. Another set of dilution plate assays
7
 by 
Mchaourab lab for a library of single Cys mutants is also shown for comparison in the last 
column. The column labeled KD lists the TPP
+







Acriflavine  EtBr KD (nM) 
Mchaourab Cys mutants- 
growth on 507 μM EtBr 
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Val + + + 
 
Grew at 1/10 diln 








Val ++ ++ ++ 
 











Val ++ ++ ++ 
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Characterization of putative dynamics mutants I went on to characterize these putative 
dynamics mutants, and evaluated whether they are indeed dynamics mutants suitable for our 
structural studies. Unexpectedly, most of the seven mutants identified have faster 
interconversion rates. For example, the mutation M21G indeed reduces the rate of drug export by 
EmrE as assessed from our in-cell export assay (Fig. 2.2). However, the TROSY-HSQC 
spectrum (Fig. 2.3) for TPP
+
-bound EmrE-M21G suggests that conformational exchange 
between open-in and open-out in EmrE is actually faster for this mutant. Although there are still 
two sets of peaks corresponding to the asymmetric dimer, there is noticeable line-broadening and 
some pairs of amide resonances are collapsing together. This is confirmed by the ZZ exchange 
experiment and the rate is around 10-15 s
-1
. This is also true for the EmrE-A59L mutant since the 
broadening of peaks due to exchange is more pronounced suggesting even faster interconversion. 
Some of the observed line-broadening may also arise from structural heterogeneity and the peak 
positions are slightly shifted, suggesting that there may be reduced asymmetry in these mutants. 
Together these results suggest that these mutants may destabilize packing of the loops needed to 
define the asymmetric closed-on-one-side structure of EmrE. This would explain enhanced 
exchange and greater structural heterogeneity. Incomplete closure of the transport pore would 
also lead to substrate leakage and prevent active efflux. 
37 
 
The mutants in TM4 (I101G, N102A, and N102V) have faster interconversion as inferred from 
the TROSY-HSQC spectra, possibly through disruption of the interface between the TM4 
dimerization motif and the TM3 kink region important for open-in and open-out exchange. This 
might be true for G90V as well, although most likely this mutation disrupts the dimerization of 
EmrE in the first place
17
, as shown by the reduced number of peaks visible in the spectrum. 
 
Fig. 2.2 Ethidium export properties for cells expressing EmrE mutants from in-cell assay. In each subfigure, the WT 
control was performed the same day. There is an additional control in lower left subfigure for D84G (WT-2). 
 































































































































Fig. 2.3 TROSY-HSQC spectra for TPP
+
-bound EmrE in DLPC/DHPC (q = 0.33) bicelles. Spectra were collected at 




Identification of EmrE-S64V as a slow dynamics mutant One mutant, EmrE-S64V, had the 
desired behavior with reduced conformational interconversion and consequently better NMR 
spectral quality (Fig. 2.4). Using ITC, I confirmed the TPP
+
 binding affinity of EmrE-S64V is 
largely the same as WT. So the reduced drug export from the in-cell assay for this mutant is not 
due to impaired drug binding and likely arises as a result of slow transport across the membrane.  
 
Fig. 2.4 EmrE-S64V is a slow dynamics mutant. The binding affinity from ITC for TPP
+
 for EmrE-S64V is similar 
to WT. The conformational interconversion rate is 1.2 ± 0.2 s
-1
 for EmrE-S64V in complex with TPP
+
 in 
DLPC/DHPC (q=0.33) bicelles at 45˚C. 
 
A more complete characterization of EmrE-S64V is demonstrated in Chapters 3 and 4. The 
conformational interconversion rate of EmrE-S64V in complex with TPP
+
 (0.6 ± 0.1 s
-1
 in 
DMPC/DHPC bicelles and 1.2 ± 0.2 s
-1
 in DLPC/DHPC bicelles) makes NMR structural studies 
of EmrE possible.  





 in DLPC/DHPC bicelles)
9
, a substrate that slows the open-in and open-out 
exchange rate of EmrE. However, EmrE-S64V is structurally more rigid or homogenous as 

















and more feasible structure determination for S64V-EmrE bound to TPP
+
 than WT-EmrE bound 
to DPhTPP
+
 even though both systems have the same rate of open-in to open-out exchange. We 
therefore pursued NMR structure determination using the S64V mutant, and further explored the 
effects of S64 mutation to better understand the factors controlling the dynamics of EmrE critical 
to its transport activity. 
 
Conclusion 
A better structure of EmrE is needed to understand the multidrug transport process of EmrE. 
However, dynamics due to the conformational interconversion between open-in and open-out 
make high-resolution structures of EmrE challenging for all structural approaches. The 
conformational interconversion needed to be reduced in order to solve the structure of EmrE 
using solution NMR. Through a collaborative comprehensive screening, we have identified 
EmrE-S64V as a slow dynamics mutant suitable for structural studies. We have also explored the 
importance of S64 in EmrE to gain insight into the mechanism coupling substrate binding and 
conformational exchange between open-in and open-out to better understand how EmrE 
performs active drug efflux. 
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References 
 
1 Fleishman, S. et al. Quasi-symmetry in the cryo-EM structure of EmrE provides the key 
to modeling its transmembrane domain. Journal of molecular biology 364, 54-67, 
doi:10.1016/j.jmb.2006.08.072 (2006). 
2 Chen, Y.-J. et al. X-ray structure of EmrE supports dual topology model. Proceedings of 
the National Academy of Sciences of the United States of America 104, 18999-19004, 
doi:10.1073/pnas.0709387104 (2007). 
3 Rule, G. S. & Hitchens, T. K. Fundamentals of Protein NMR Spectroscopy.  (Springer 
Netherlands, 2005). 
4 Morrison, E. et al. Antiparallel EmrE exports drugs by exchanging between asymmetric 
structures. Nature 481, 45-50, doi:10.1038/nature10703 (2012). 
5 Vaidehi, N., Grisshammer, R. & Tate, C. G. How Can Mutations Thermostabilize G-
Protein-Coupled Receptors? Trends in pharmacological sciences 37, 37-46, 
doi:10.1016/j.tips.2015.09.005 (2016). 
6 Serrano-Vega, M. J., Magnani, F., Shibata, Y. & Tate, C. G. Conformational 
thermostabilization of the 1-adrenergic receptor in a detergent-resistant form. 
Proceedings of the National Academy of Sciences 105, 877-882, 
doi:10.1073/pnas.0711253105 (2008). 
7 Amadi, S. T., Koteiche, H. A., Mishra, S. & McHaourab, H. S. Structure, dynamics, and 
substrate-induced conformational changes of the multidrug transporter EmrE in 
42 
 
liposomes. The Journal of biological chemistry 285, 26710-26718, 
doi:10.1074/jbc.M110.132621 (2010). 
8 Tate, C. G., Ubarretxena-Belandia, I. & Baldwin, J. M. Conformational changes in the 
multidrug transporter EmrE associated with substrate binding. Journal of molecular 
biology 332, 229-242, doi:10.1016/S0022-2836(03)00895-7 (2003). 
9 Morrison, E. A. & Henzler-Wildman, K. A. Transported substrate determines exchange 
rate in the multidrug resistance transporter EmrE. The Journal of biological chemistry 
289, 6825-6836, doi:10.1074/jbc.M113.535328 (2014). 
10 Morrison, E. & Henzler-Wildman, K. Reconstitution of integral membrane proteins into 
isotropic bicelles with improved sample stability and expanded lipid composition profile. 
Biochimica et biophysica acta 1818, 814-820, doi:10.1016/j.bbamem.2011.12.020 
(2012). 
11 Li, Y. & Palmer, A. G. TROSY-selected ZZ-exchange experiment for characterizing 
slow chemical exchange in large proteins. Journal of biomolecular NMR 45, 357-360, 
doi:10.1007/s10858-009-9385-0 (2009). 
12 Miloushev, V. Z. et al. Dynamic properties of a type II cadherin adhesive domain: 
implications for the mechanism of strand-swapping of classical cadherins. Structure 
(London, England : 1993) 16, 1195-1205, doi:10.1016/j.str.2008.05.009 (2008). 
13 Delaglio, F. et al. NMRPipe: A multidimensional spectral processing system based on 
UNIX pipes. Journal of Biomolecular NMR 6, 277-293, doi:10.1007/bf00197809 (1995). 
14 Vranken, W. F. et al. The CCPN data model for NMR spectroscopy: development of a 
software pipeline. Proteins 59, 687-696, doi:10.1002/prot.20449 (2005). 
43 
 
15 Korkhov, V. M. & Tate, C. G. Electron crystallography reveals plasticity within the drug 
binding site of the small multidrug transporter EmrE. Journal of molecular biology 377, 
1094-1103, doi:10.1016/j.jmb.2008.01.056 (2008). 
16 Gayen, A., Banigan, J. R. & Traaseth, N. J. Ligand-induced conformational changes of 
the multidrug resistance transporter EmrE probed by oriented solid-state NMR 
spectroscopy. Angewandte Chemie (International ed. in English) 52, 10321-10324, 
doi:10.1002/anie.201303091 (2013). 
17 Elbaz, Y., Salomon, T. & Schuldiner, S. Identification of a glycine motif required for 
packing in EmrE, a multidrug transporter from Escherichia coli. The Journal of 
biological chemistry 283, 12276-12283, doi:10.1074/jbc.M710338200 (2008). 
18 Dutta, S., Morrison, E. A. & Henzler-Wildman, K. A. EmrE dimerization depends on 










Structure determination by NMR spectroscopy relies on multidimensional NMR experiments 




N stable isotopes (plus 
2
H for large systems) to 
determine resonance frequencies of nuclei in the protein
1
. This resonance assignment step is 
necessary for further studies of the structure (and dynamics). To determine the 3D structure, 
conformational restraints are then collected which usually consist mainly of proton-proton 
distance restraints and dihedral angles restraints.  These conformational restraints are integrated 
with physicochemical knowledge of protein structures in the force field to calculate final 
structures.  
Resonance assignment 
NMR assignment experiments can be grouped into two major categories: through-bond 
experiments and through-space experiments. In through-bond experiments, connectivities are 







backbone-walk experiments correlate nuclei in neighboring residues through scalar couplings 
and are the most commonly used experiments for backbone resonance assignment. The 
sensitivities of different experiments depend on the transfer efficiencies, which are related to the 
scalar coupling constants (Fig. 3.1). These backbone-walk experiments greatly simplify spectral 
analyses due to their simplicity since often only one or two peaks are associated with a root 
resonance. Highly deuterated proteins can be used for backbone-walk experiments, making them 
suitable for backbone assignment of large systems with the constraint that only experiments 
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beginning on HN can be used because the other protons have been replaced by deuterium. Thus, 
the out-and-back HNCACB must be used instead of CBCANH. 
 
Fig. 3.1 Scalar coupling constants in proteins. Figure from Ferella et al., 2012. 
 
COSY (Correlation spectroscopy) and TOCSY (Total correlation spectroscopy) experiments, 
which are used mainly for side chain assignment of small proteins, belong to another major class 
of through-bond experiments. In COSY experiments, cross-peaks between pairs of vicinal 




J scalar couplings (protons that are connected by more than three 
bonds give no cross-peaks since 
4
J and above are close to 0). In TOCSY experiments, 
magnetization is transferred to the entire spin system of an amino acid by successive scalar 
couplings. So in addition to cross-peaks that appear in COSY spectra, there will be cross-peaks 
corresponding to interactions of protons connected by more than three bonds. The challenge for 
using these experiments in large systems lies at the tricky balance between the need for 
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deuteration and detectable protons. The fast relaxation of signals in highly protonated systems 
prevents the use of many coherence transfer steps, and the use of deuteration eliminates 
detectable protons. 
Assignments can also be aided by through-space experiments. In through-space experiments, 
dipolar couplings of nuclei occur as a result of spatial proximity and are independent of the 
presence of chemical bonds between them. In nuclear Overhauser effect spectroscopy (NOESY) 
experiments, cross-peaks for pairs of protons within 5-6 Å are observed. These connectivities in 
space provide tertiary restraints, but may also help in sequential resonance assignment due to the 
short-range nature of NOE peaks. This is especially useful in regions containing secondary 
structures
2
. NOESY data is used more often to aim resonance assignment in large systems to 
resolve ambiguity due to peak overlap, and assist in regions where backbone-walk experiments 
have lower sensitivity since the coherence transfer experiments based on scalar couplings suffer 
from shorter transverse relaxation times in high molecular-weight systems. In NOESY 
experiments, however, magnetization is stored along the Z axis therefore the slower longitudinal 
relaxation is in effect and good quality spectra can be obtained for larger systems. However, care 
must be taken since NOE spectra contain peaks due to not only short-range intra and inter-
residue but also medium- and long-range contacts. 
Structural restraints 
The major sources of structural restraints for NMR structure determination are distance restraints 
derived from NOEs between nearby hydrogen atoms. NOE distance restraints are crucial to 
define the overall protein fold. However, as the NOE only reports information about local 
structural features, a large number of NOEs are needed to reconstruct the overall structure
3
. 
Unfortunately, it is more difficult to collect enough NOE restraints to determine the structure for 
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larger systems due to ambiguity arising from resonance overlap, inability to fully assign side 
chain resonances, and simple lack of side chain data due to deuteration. 
Additional NMR conformational restraints are often used in addition to NOEs to assemble the 
3D structure. Backbone dihedral angles, useful structural restraints to define secondary structure, 
are determined from the backbone resonance assignment using amides, CA, CB, and CO 
chemical shifts by comparing the chemical shifts to those of short stretches of peptides in a 
database using TALOS-N
4
. Residual dipolar couplings (RDCs) rely on the reintroduction of a 
residual alignment (~0.1%), so the molecules still tumble quickly to obtain high-resolution 
solution NMR spectra, but are aligned just enough to measure residual anisotropic information, 
such as dipolar coupling, to obtain orientational restraints. The key advantage of RDCs is that 
these orientational restraints are measured relative to the common molecular frame and are thus 
good complements to NOE distance restraints which may accumulate errors in the process of 
assembling local structural features
5
. 
Early NMR structure determinations of small proteins used distance geometry (based on a large 
amount of NOEs) to calculate structures. For large systems, NMR data alone would not be 
enough to determine all the atomic coordinates in the molecule. During structural calculation, 
usually a primitive force field is used where the ideal covalent structure is maintained and only 
the steric repulsion is active. Then all the NMR restraints are converted into energetic potentials 
to guide the structure calculation towards energetic minimums. NMR structure determination 
from resonance assignment to structural calculation is a highly iterative process as restraints are 
incorporated and structures refined. 
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Methyl labeling – an approach to overcome the challenges of large proteins 
NMR is one of the three major techniques, the other two being X-ray and cryoEM, that could 
lead to high-resolution structures of biomolecules. In fact, NMR-derived structures account for 
10% of the PDB archive. However, an NMR-derived structure is not an image of the molecule in 
the sense that an X-ray structure is. Rather, the process of structure determination using NMR is 
to assemble a lot of indirect structural evidences into 3D structures
3
. So as the molecule gets 
larger and more complicated, NMR structure determination becomes significantly more 
challenging. This is one major reason why most of the structures solved by NMR tend to be 
small (Fig. 3.2). Besides, for solution NMR, large molecules tumble slowly in solution. This 
leads to a fast decay of NMR signals therefore low signal-to-noise ratio and low resolution of 
resulting peaks. Meanwhile, the large number of signals present severe peak overlap problem in 
NMR spectra. So structure determination by NMR is challenging for systems larger than 25 kDa. 
One strategy for overcoming the challenges of studying large systems by NMR is the use of 
methyl labeling. Isotopic labeling of methyl groups of Ile, Leu, and Val residues provides a nice 
opportunity for side chain resonance assignment and restraints collection for high molecular-
weight systems by introducing a limited set of protons to provide distance restraints within an 
otherwise highly deuterated molecule. Due to the fact that the three protons of each methyl group 
are equivalent as a result of the rapid rotation around the threefold axis, NMR experiments on 
methyl groups deliver high sensitivity and favorable relaxation properties even for really high 
molecular-weight systems
6
. Also methyl groups tend to localize to the hydrophobic cores of 
proteins so they are excellent reporters of structures and dynamics, especially for soluble 
proteins. The linearized labeling scheme, where only Ile-δ1 and one of the two methyl groups of 
Leu and Val are 
13
CH3-labeled using α-ketoacids, paved the way for NMR assignment 
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experiments designed to link methyl groups to Cα/Cβ/C’ or even to NH, which usually are 




Fig. 3.2 NMR structure determination is challenging for membrane protein systems. Left, the molecular weight 
distributions of structures solved by NMR, X-ray, and cryoEM. Figure from Ferella et al., 2012. Right, the 
distributions of integral membrane protein structures solved by NMR (both solid-state and solution NMR) according 
to the number of unique transmembrane helices (TM). The statistics was based on drorlist on membrane protein of 
known structure by NMR as of Apr. 15
th
, 2015.  
 
Challenges of NMR structure determination of membrane proteins 
Currently, there are fewer than 200 membrane protein structures that have been solved by NMR, 
as a result of the following factors. First of all, membrane protein biochemistry is difficult, which 
is why there has only been a burst of membrane protein structures determined in last decade by 
any structural method. Second, membrane proteins need a membrane-mimetic environment to be 
folded and functional. Thus, even a small membrane protein behaves as a large one due to the 
overall size of the protein-micelle/bicelle/nanodisc/lipodisq complex, and all the challenges 
involved in solution NMR studies of large systems apply.  Alpha helical integral membrane 
proteins belong to an even more challenging subclass, because the chemical shift dispersion is 
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generally limited and there are fewer long-range tertiary interactions available to define the 3D 
structure. Solid-state NMR spectroscopy has made great advances in the last decade and can be 
used to determine the backbone fold of membrane proteins in a lipid bilayer
8,9
. However, peak 
overlap and limited side chain data still present challenges, as in solution NMR approaches. 
Challenges involved in NMR structure determination of EmrE  
There are additional layers of difficulty in the NMR structure determination of EmrE. Although 
EmrE has only 110 amino acids in the primary sequence, the functional unit is an antiparallel 
dimer. So in the structure of EmrE, the number of unique transmembrane (TM) helices is eight 
which is daunting (Fig. 3.2) considering only five integral membrane protein structures with 6 or 
7 TM helices have been solved thus far using NMR approaches
10-14
. What is more, although the 
two monomers assume different conformations in the asymmetric dimer of EmrE, the two sets of 
TM helices give similar NMR signals in many places, complicating resonance assignment. While 
these increase the difficulty, there is a final major hurdle that makes NOE-based structure 
determination of WT EmrE in complex with TPP
+
 not feasible: the constant conformational 
interconversion of EmrE between open-in and open-out states. This conformational 
interconversion process, occurs at 5 s
-1
 in our NMR conditions, so cross-peaks from 
conformational interconversion will build up in the NOESY spectra with a much shorter mixing 
time than necessary for NOE build up and measurement (up to a few hundred ms). Therefore, we 
focused on solving the structure of the S64V mutant of EmrE where it is possible to get useful 
NOE distance restraints due to its reduced rate of conformational exchange.  
In what follows, I summarize our efforts towards a better structure of EmrE using the S64V-
EmrE bound to TPP
+
 in bicelles. 
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Materials and methods 
Protein expression and purification EmrE was expressed, purified, and reconstituted into 
isotropic bicelles as previously described
15-17
 with some modifications. When OD600 was close to 
0.9-1.0, IPTG was added into cell cultures which were cooled down on ice
18
. This was found to 
increase EmrE yield. During the detergent extraction stage, the membrane fraction from the first 
high-speed spin was solubilized with 40 mM decylmaltoside (DM, Anatrace) overnight to 
increase protein extraction by detergent for high yield samples. 
Sample preparation NMR data, unless stated otherwise, were collected on samples containing 
0.8-1.5 mM EmrE in DMPC/DHPC bicelles (q = 0.33) with a protein to DMPC molar ratio of 
1:50-100 at pH 7, 45 ˚C. Samples also contained 100 mM MOPS, 10-30 mM NaCl, 2 mM 
TCEP, and 8-10% D2O. The use of 100 mM MOPS instead of the previously used 20 mM 
phosphate buffer provided higher pH buffering capacity crucial for long time NMR experiments, 





-bound EmrE, 1-2 mM TPP
+






N samples for 2D TROSY-HSQC, ZZ-exchange experiments, H/D exchange, and 
temperature titration were isotopically labeled by growing cells in D2O M9 media supplemented 
with 2 g/L glucose, 1 g/L 
15















N samples for pH titration were prepared similarly but the final buffer system was 20 mM 















C glucose, 1 g/L 
15






N ISOGRO. This sample was reconstituted 
into D54-DMPC/D22-DHPC bicelles with extensively deuterated acyl chains. 
1-
13
C amino acid selective labeling samples were produced by growing cells in D2O M9 media 
supplemented with 1.5-2 g/L glucose, 1 g/L 
15




N ISOGRO. Before 
IPTG induction, each 1-
13
C amino acid was added into the media and incubated for 15-30 
minutes. For each amino acid labeling, cell cultures were supplemented at least four fold of the 
amount of that amino acid present in ISOGRO
22


























N ISOGRO). None of these amino 
acid labeling samples resulted in significant scrambling.  
A 50% randomly deuterated 
15
N sample was prepared by growing cells in ~50% deuterated M9 
media supplemented with 2 g/L glucose, 1 g/L 
15









N sample was prepared by growing cells in ~50% deuterated 
M9 media supplemented with 2 g/L 
13
C glucose, 1 g/L 
15
















C glucose, 1 g/L 
15






N ISOGRO. The sample was reconstituted 
into D54-DMPC/D22-DHPC bicelles. The final sample was in D2O based buffer. 
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, 1 g/L 
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N ISOGRO. The sample was 
reconstituted into D54-DMPC/D22-DHPC bicelles. 














N]  ILV sample 




C glucose, 1g/L 
15






N ISOGRO. Before the induction, 120 mg/L 
alpha-ketoisovaleric acid (1, 2, 3, 4-
13
C4, 99%; 3, 4’, 4’, 4’-D4, 97-98%) and 70 mg/L alpha-
ketobutyric acid (
13
C4, 98%; 3, 3-D2, 98%) were added into the media
7
. The sample was 
reconstituted into D54-DMPC/D22-DHPC bicelles. 2 mM deuterated TPP
+



















C pyruvate alternate labeling
25
 sample was prepared by growing cell in H2O M9 media 
supplemented with 3 g/L 2-
13
C pyruvate, 1 g/L NaH
13
CO3, and 1 g/L 
15
NH4Cl. For pyruvate 
labeling, the pH of media needed to be closely monitored and adjusted before induction. The 
sample was reconstituted into D54-DMPC/D22-DHPC bicelles. 
Samples for measuring residual dipolar couplings under the isotropic condition were prepared 
similarly and loaded into a Shigemi tube as most samples. For the aligned condition, the same 
sample was pH adjusted and then soaked into stretched polyacrylamide gels generated using a 
simple gel press apparatus (New Era)
26
. Briefly, the gel chamber was cleaned using nitrogen gas 
and parafilmed on the bottom. Then 1 ml of newly prepared 3.8% polyacrylamide gel solution 
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(2.1 ml 3.8% neutral gel: 1.306 ml H2O, 0.572 ml 1.25 M pH 6.6 bis-tris buffer, 0.2 ml 40% 19:1 
acrylamide/bis solution, 12 μl 10% ammonium persulfate, 10 μl 10% TEMED) was added into 
the chamber and 0.2 ml isopropanol was placed on top to avoid air contact. The gel was allowed 
to polymerize overnight before it was washed with water twice, the final buffer twice, and water 
twice again. Then the gel was cut on a piece of parafilm to a desired length (0.4-0.5 cm for 400 
μl sample) and transferred to a petri dish which was coated with 100 μl silicone oil to reduce the 
contact between the gel and the surface. The gel was carefully rotated several times and let dry 
for a day. Then the dried gel was placed in the chamber with bottom parafilmed and the sample 
was added into the chamber (the final protein to long-chain lipid ratio was 1:50 which was 
critical for successfully soaking the protein-bicelle sample into the gel for alignment). The 
soaking process took at least one day. After the soaking was done, the gel press apparatus was 
assembled and the gel was loaded into an open-ended sample tube (connection from bottom to 
top: sample tube – funnel – chamber – piston (o-ring on top) – cap – piston driver). Then the 
piston driver was used to push the gel into the tube. After most of the gel was loaded, the 
chamber was unscrewed and the gel was further pushed into the tube by pipetting with 1 ml tip. 
At last, the bottom of the tube was sealed with an end-plug and a plunger was inserted on top. 
NH RDC sample was prepared by growing cells in D2O M9 media supplement with 2 g/L 
glucose, 1g/L 
15




N ISOGRO.  















NMR spectroscopy and data analysis NMR data were collected at 45 ˚C on a Varian 700 MHz 





 and analyzed in CcpNmr Analysis
28
. Non-uniform sampling (NUS) 
was used to increase both resolution and sensitivity for all 3D experiments
29
. Possion gap 
sampling
30





 were used for spectral reconstruction from NUS data. All 
NOESY exchange used a mixing time of 150 ms to allow cross-peaks to build up while avoiding 
peaks from conformational exchange. 
For backbone assignment, TROSY-HNCA and TROSY-HNCACB backbone-walk experiments 






N labeled sample on a Varian 800 MHz spectrometer with a 
cryoprobe at NMRFAM. A TROSY-selected ZZ-exchange spectrum with a 200 ms mixing time 




N EmrE sample in DLPC/DHPC bicelles (kconf is 1.2 s
-1
) and used to 
facilitate assignment of each pair of exchange-related amides. For each 1-
13
C amino acid 




N background, 2D TROSY-HSQC, a ZZ-exchange plane with 200 ms 




N plane of TROSY-HNCO were taken. A series of TROSY-HSQC 




N samples for pH titration (4.5-9.0), temperature titration (15-
45 ˚C), gadobenate dimeglumine titration (0-5 mM), and H/D exchange. 
For methyl assignment, a methyl protonated ILV sample was used to collect a series of 3D 
experiments to link methyl groups of ILV residues back to assigned Cβ, Cα, C’, and NH groups
7
. 
In addition, a time-shared 3D C, N-HMQC-NOESY-TROSY and 3D C, N-HMQC-NOESY-
HMQC were collected. All experiments involving methyl groups here used selective pulses on 
the methyl proton to reduce lipid signal contamination (mostly from the non-deuterated head 
groups of the lipids). These experiments were collected on a Varian 800 MHz spectrometer with 
a cryoprobe at NMRFAM. 
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For residual dipolar couplings (RDCs) measurement, we used intensity-based methods to 
measure RDCs for NH and NC’ bond vectors since for large systems spectral overlap forbade 
frequency-based methods. We used ARTSY
33
 for NH bond RDCs measurement. For both 
isotropic and aligned condition, the reference and attenuated spectra were collected in an 
interleaved manner. The delay T was set to 10.75 ms for the isotropic condition and 9.5 ms for 
the attenuated condition. For each condition, both reference and attenuated spectra were 
processed using the same script. The peak list from the reference experiment was used to find 
corresponding peak locations in the attenuated experiment. The peak intensity ratios of the two 
spectra were used to calculate coupling constants. RDCs were calculated from the difference 
between coupling constants of the isotropic and aligned experiments. 
NC’ RDCs were collected using a TROSY-based J-modulation method
34
. Due to the much 
smaller NC’ J coupling constants, a series of modulation points were needed to more precisely fit 
the coupling constants. For both isotropic and aligned conditions, the modulation time points 10 
ms, 50 ms, 70 ms, and 90 ms were used. For each time point, both reference and attenuated 
spectra were processed using the same script. The peak list from the reference experiment was 
used to find corresponding peak locations in the attenuated experiment. The peak intensity ratios 
of the reference and attenuated experiment at different modulation time points were used to fit 
coupling constants. The NC’ RDCs were calculated as differences between fitted coupling 
constants from the aligned and isotropic conditions. These experiments were performed on a 
Varian 900 MHz spectrometer with a cryoprobe at NMRFAM. 
The 50% randomly deuterated 
15
N sample was used to collect a 3D 
15
N-NOESY-TROSY 
spectrum. This was collected on a Bruker 900 MHz spectrometer with a cryoprobe at the 









N sample was used to collect a 3D NOESY-HSQC (carbon aliphatics), a 3D 
NOESY-HSQC (carbon aromatics), a 3D HCCH-TOCSY, and a 3D CCH-TOCSY experiment. 
These were collected using a Varian 800 MHz spectrometer with a cryoprobe at NMRFAM. 




N sample was used to collect a 3D NOESY-HSQC (carbon 
aliphatics), a 3D NOESY-HSQC (carbon aromatics), a 3D HCCH-TOCSY, and a 3D CCH-
TOCSY experiment. 
The methyl CHD2 sample was used to collect a 3D NOESY-HSQC (carbon aliphatics), a 3D 




C glucose sample was used to collect a 3D NOESY-HSQC (carbon aromatics) and a 3D 
filtered/edited NOESY-HSQC for aromatic assignment and protein-ligand NOE collection.  
Preliminary Xplor-NIH structure calculations were performed to evaluate the restraints needed 
for structure calculation. TPP
+
 force field parameters were generated using ACPYPE
35
. 
Molecular Dynamics Flexible Fitting and Molecular Dynamics Due to the approximately 4 Å 
resolution in the available crystal structure, only Cα positions are reported. The positions of the 
Cα atoms form the TPP
+
-bound crystal structure (PDBID: 3D5D) were used to restrain a model 
of EmrE generated using a combination of PSFGEN and MODELLER, effectively using the 
available Cα positions as a template as the side chain and backbone shake out any instabilities. 
However, the initial structure lacked α-helical secondary structure throughout the hydrophobic 
transmembrane regions of the protein. Furthermore, the crystal structure placed a number of 
proline residues in the loop regions between helical domains, rather than as helix terminators 
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where they are far more commonly found. Thus considerable effort was initiated to use available 
experimental information and other membrane protein trends to refine the model to better 
approximate the in vivo state. Besides the crystal structure, there is also a cryoEM based model 
available, as well as the original electron density used to construct the model. This cryoEM map 
was combined with Molecular Dynamics flexible Fitting (MDFF) 
36-38
, where additional forces 
added to molecular simulation attract atoms to areas of electron density, to refine the initial 
structural model. This was achieved through two broad steps, simulation of the naked protein in 
a high-dielectric (ε = 80) implicit solvent model, and embedding this model into an atomistic 
membrane representation for further relaxation with additional electron density restraints. This 
split was done so that the large structural changes required could be done interactively. After the 
large structural changes were achieved, further equilibration was carried out in a membrane 
environment.  
 
Results and discussion 
My efforts towards a better structure of EmrE are presented in three main sections: backbone 
assignment, side chain assignment, and structural restraint collection. But structure determination 
of macromolecules using NMR is an iterative process, and spectral analyses of all three parts 
were done simultaneously. 
Backbone assignment We have used a non-standard assignment strategy to combine backbone-
walk data with ZZ-exchange, amino-acid specific labeling, solvent accessibility, and backbone 
NOESY data to achieve a near complete backbone assignment. That is, we have assigned 98.1% 
(206/210) amides, 98.6% (217/220) Cα, 92.8% (182/196) Cβ, 96.8% (213/220) C’. 
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N sample to record TROSY-
HNCA, TROSY-HN(CO)CA, and TROSY-HNCACB spectra. The use of perdeutration and 
TROSY experiments for this slow tumbling protein-bicelle system are crucial to suppress spin 
diffusion and retain favorable lineshape properties of spin systems. In addition, the use of non-
uniform sampling
29
 was necessary to make all 3D experiments possible considering the long 
experimental time needed as a result of low sensitivities of NMR experiments for this large 
protein-bicelle system. The most sensitive pair of backbone-walk experiments, HNCA and 
HN(CO)CA, were used to connect Cα(i-1) and Cα(i) resonances. The Cβ chemical shifts from 
HNCACB, especially those of Ala, Ser, and Thr, provided additional clues for spin system 
assignments. Cβ(i-1) data was used whenever available. The conformational interconversion that 
caused a lot of problems in our NMR experiments was leveraged here for assignment as the ZZ-




Fig. 3.3 Backbone assignment from backbone-walk and ZZ-exchange data. HNCA strips (top panel) from TROSY-
HNCA experiments were shown to illustrate the concept of backbone-walk for a sequence from residue 81 to 84 
(QRLD) for both chains of EmrE. In addition to that, the assignment was confirmed using ZZ-exchange data 
(bottom panel: red, TROSY-HSQC; blue, a ZZ plane with 200 ms mixing time). For each pair of exchange-related 
amides, the next two residues suggested from backbone-walk should lead to another pair of exchange-related 
amides. 
 
We also used 1-
13




N background to generate starting 
points for assignments
22
. This specific labeling for each amino acid used here (G/A/V/L/I/Y) 
generated the following information (Fig. 3.4). First, missing peaks in the TRSOY-HSQC 
spectrum of an amino acid labeled sample indicate the corresponding residue type of that peak is 
the specifically labeled amino acid. Second, in the amide plane of the HNCO experiment, only 
peaks from residues immediately following the labeled amino acid will appear. This amino acid 
specific labeling was particularly helpful in crowded regions, and provided multiple anchor 
points and information to fill gaps where Cα(i-1) peaks are missing in the HN(CO)CA.  
 
Fig. 3.4 Backbone assignment from 1-
13




N background illustrated using a 
model peptide system (sequence: MGAVT). The HSQC spectrum for the uniformly 
15
N labeled peptide was 
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illustrated in the left. The HSQC and the amide plane of HNCO spectra were shown in right for a 
15
N labeled sample 
with 1-
13
C alanine selective labeling. Because of the use of 1-
13
C alanine, peaks from alanine residues will disappear 
from HSQC. Meanwhile, only peaks corresponding to residues that are after alanine in sequence will appear in the 




-bound EmrE has an asymmetric architecture, we need to assign resonances to the 
correct monomer. Backbone-walk data will have breaks due to Pro residues, lack of signal, or 
overlap in the Cα chemical shift that provided the primary backbone connectivity. The overlap 
problem is further exaggerated by the nature of NMR of α-helical membrane proteins, which 
have reduced chemical shift dispersion. Therefore, ambiguity in chain assignment was a 
significant problem. In addition to backbone-walk data, another major source of information for 
chain assignment was from a NOESY walk using the N-N NOESY data. Taking advantage of the 
α-helical secondary structure, we used NOE peaks connecting neighboring residues as another 
source of reference when the chain assignment was ambiguous from available backbone-walk 
Cα and Cβ data. We used water accessibility data to help chain assignment in the loop regions, 
since the asymmetric EmrE is open to water on one side but not the other
15
. Also, while we know 
that the binding site of EmrE is asymmetric, our iterative assignment gradually converged to 
suggest one set of peaks corresponding to a single monomer is more involved in ligand binding 
and the other set of peaks corresponding to the other monomer is sensitive to pH 
21
 (and other 
sample condition changes). Therefore, we have used this information to revise our chain 
assignment.  
The backbone assignment was also facilitated from side chain methyl assignment. In addition, in 
collaboration with Emad Tajkhorshid lab from UIUC, our assignment efforts were also 
supported by a MDFF refined EmrE structure using both the X-ray structure and cryoEM 
electron map (Fig. 3.5). Integrative assignment and modeling efforts were performed to guide 
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initial resonance assignment based on assignment possibilities and identify possible errors. This 
refined EmrE structure has a lot of structural features that are supported by our NMR data, and 
provides a good starting structure for final structure calculation which will dramatically reduce 
the sampling space.  
 
Fig. 3.5 Structural model of EmrE constructed using MDFF. The monomer A is in blue, and the monomer B is in 
red. A green sphere has been drawn on the C-terminus of each monomer to help identify the loops. Proline residues 
3, 32, 55, and 86 are also drawn to highlight their important role in terminating helices in the refined model. 
Structure modeled by Josh V. Vermaas in Emad Tajkhorshid lab. 
 
Using these strategies, we have achieved a near complete backbone resonance assignment (Fig. 












As previously mentioned, the chemical shifts from one monomer titrated more as the pH drifts 
down. From our earlier studies and assignments here (and unpublished molecular dynamics 
simulation studies which supports a higher pKa value for E14 in monomer B), we know that 
monomer B titrates more strongly with pH (Fig. 3.7). Here I have plotted the chemical shift 
differences between pH 7 and 6 for residues in both monomer A and B. Immediately, there are 
two main regions in monomer B that respond to pH changes: one is near the E14 residue which 
becomes protonated and the other is the TM3 kink region. While it makes sense that peaks from 
residues close to E14B will titrate, the discovery that the largest chemical shift changes are from 
TM3 kink region in TM3 is very interesting, especially considering the chemical shift changes 
are much larger (e.g. more than 2 ppm change for G67 in monomer B) than usually seen in the 
literature. This could be rationalized by ring current effect associated with movements of 
aromatic residues in the binding site as well as the ligand TPP
+
 with its four phenyl rings. This is 
mechanistically intriguing as it suggests that the protonation of E14B is coupled to the TM3 kink 
region, a critical region for the conformational interconversion process as will be demonstrated 




Fig. 3.7 Chemical shift differences between pH 6 and 7 as a function of residue number. 
 
With the near complete backbone resonance assignment, it became clear that the C-terminus 
from monomer A samples a minor state. This is evidenced by the presence of additional minor 
peaks (Fig. 3.8) for residues in the C-terminus of monomer A and the loop region connecting 
TM3 and TM4 in monomer B, which is on the same face of the asymmetric dimer as the 
monomer A C-terminus. Arg106 from monomer A is very sensitive to the identity of bound 
ligand
17
 as well as sample conditions. It is very clear that there is an additional minor state for 
Arg106 in monomer A but not in monomer B. This is supported by molecular dynamics 
simulations showing the C-terminus of monomer A is conformationally much more 
heterogeneous compared to the other C-terminus of monomer B. Interestingly, one molecular 
dynamics simulation shows the C-terminus of monomer A is extending into the binding site, 
interacting with residue E14B. As will be demonstrated in Chapter 5, the C-terminus of 
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monomer A is undergoing microsecond timescale motions in WT EmrE. This minor state might 
be a general feature in EmrE that is not seen in WT spectra due to lower signal-to-noise ratio and 
perhaps the difference in conformational exchange timescale. 
 
Fig. 3.8 The C-terminus of monomer A of EmrE samples a minor state. The set of minor peaks were shown for 
residues R106 and Thr108 in the C-terminus of monomer A, as well as residues R82B and L83B in the loop 
connecting TM3 and TM3 in monomer B. This minor population of the C-terminus in monomer A was also 
observed in molecular dynamics simulations (work by Josh Vermaas) where R106 from monomer B would protrude 
into the binding site and is conformationally more heterogeneous than that of the other monomer. 
 
This observation of a minor state in the C-terminus of monomer A is very intriguing since it 
might have a functional role. EmrE is a proton-coupled transporter, and our recent NMR data 
demonstrates that it violates the long-standing single-site alternating access model and is able to 




































symmetric membrane conditions. If true, this would suggest that EmrE should leak protons, 
however, proton leak measured in liposomes is slower than expected under ΔpH and not 
detectable with a membrane potential. Since the C-terminus contains Arg106 and His110, it is 
interesting to speculate whether it might function as a cap on the binding site to prevent proton 
leakage. Movement of the C-terminus into the transport pore blocking water access would result 
in these charges effectively moving partway through the membrane potential and could alter the 
kinetics and thermodynamics related to the  conformational exchange process
39
. 
Side chain assignment Restraints involving side chain groups are important to define the tertiary 
structure of a protein. But side chain assignment for large systems in general is very difficult. 
First of all, the complete side chain assignment is impossible as a result of very low sensitivity 
and severe spectral overlap. For partial side chain assignment, unlike backbone resonance 
assignment, there is a major consideration for balance between the need for deuteration and 
detectable protons. Higher levels of deuteration suppress spin diffusion and reduce spin 
relaxation since deuterium has a much smaller gyromagnetic ratio (γD/γH ~ 1/6.5), therefore 
improving both sensitivity and resolution. But the deuteration also reduces the number of 
detectable protons, therefore providing fewer restraints. As a result of the high cost and limited 
life of each sample, we tried a variety of labeling strategies to explore a cost-effective side chain 
assignment strategy for EmrE.  




N labeled sample to test sensitivity in TPP
+
-bound 
EmrE-S64V bicelle system. Encouragingly, we collected reasonable 2D carbon spectra for the 
aliphatic region (Fig. 3.9) even for this fully protonated sample. For this sample, the 
HCCH/CCH-TOCSY experiments could transfer magnetization from terminal methyl to Cβ 
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position for ILV residues. However, as can be seen from the spectra, the proton dimension of 




H dipolar coupling in the fully protonated sample.  





labeled sample. The deuteration effectively cut off spin diffusion improving relaxation 
properties. But additional complications arise from the random proton incorporation into methyl 
groups resulting in a collection of different isotopomer species
40
. This rendered the already 
crowded spectra even more problematic, therefore making it hard to initiate side chain 
assignment from these data. 
 






N labeled EmrE-S64V in complex with 
TPP
+




We then tried the Otten labeling scheme
23




C glucose in 
100% D2O. This labeling scheme has been demonstrated to generate a cost-effective sample for 
methyl group assignment of proteins up to 50 kDa. This labeling scheme produces proteins that 
have highly deuterated Cα and Cβ, and ~50% CHD2 for terminal methyl groups. As a result of 
the high level of deuteration at Cα and Cβ positions, magnetization can be transferred along the 
side chain without much loss to the terminal methyl groups. Only CHD2 labeled methyl groups 
are selected for detection so the spectrum looks relatively clean (Fig. 3.10). But the CHD2 
detection in the pulse sequence reduces the sensitivity. This is on top of the already reduced 
effective concentration of useful methyl isotopomer species. Again, these set of data provide 




Fig. 3.10 Constant-time carbon HSQC for the methyl CHD2 labeled EmrE-S64V in complex with TPP
+
 at 45˚C. The 
spectrum was acquired on a Varian 900 MHz spectrometer with a cryoprobe. 
 
Using the above samples, we have collected a lot of NOESY spectra which contain many 
potential distance restraints. From these efforts, we were encouraged by the signal we got from 
these rather proton-rich samples of the EmrE-S64V system. However, resonance assignment 
from these spectra turned out to be rather difficult and we realized that to initiate side chain 
assignment we need clean specific labeling schemes where high level of deuteration is 
introduced to both simply the spectra and boost sensitivity. Here I have shown the proton 
distribution (Fig. 3.11) for two main categories of side chains that we have decide to focused on 
for side chain assignment and structural restraints collection. One category includes ILV methyl 
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groups, and the other includes aromatics residues (WYF) important for defining the binding 
pocket of EmrE based on our collective NMR and modeling analysis.  
 
Fig. 3.11 Proton distribution in EmrE important for NMR structure determination. The modeled structure using 
MDFF based on cryoEM map was showed in ribbon with the ligand TPP
+
 (magenta) shown explicitly. Methyl 
groups from ILV are shown in black. Residues involved in ligand coordination in the modeled structure are shown 
as well with aromatics residues in ball-and-stick. 
 
ILV methyl assignment Isotopic labeling of methyl groups of Ile, Leu, and Val residues provides 
a set of side chain resonance upon which assignment and restraints collection is still amenable to 
high molecular-weight systems. For membrane proteins, despite the fact that a significant portion 
of methyl groups face lipids and therefore do not provide useful restraints, there are still a large 
portion of methyl groups that are very useful to define helix packing and lay the foundation for 
assignment of other side chain resonances. So we made use of the ILV labeling scheme to 




Fig. 3.12 Constant-time carbon HMQC for the selectively protonated ILV sample for EmrE-S64V in complex with 
TPP
+
 at 45˚C. The spectrum was acquired on a Varian 800 MHz spectrometer with a cryoprobe. 
 
A methyl protonated ILV sample was prepared which generated really clean methyl spectra for 
Ile-δ1, Leu-δ, and Val-γ methyl groups (Fig. 3.12). We collected a series of 3D experiments to 
link methyl groups of ILV residues back to assigned Cβ, Cα, C’, and NH groups
7
. A 3D 
HMCM[CG]CB/CA experiment was performed twice; one with two C-C COSY transfer steps to 
reach Cβ for Leu/Ile and Cα for Val, and the other one with three C-C COSY transfer steps to 
reach Cα for Leu/Ile/Val (opposite sign for Val peaks) (Fig. 3.13 and Fig. 3.14). A 3D Ile/Leu-
HMCM(CGCBCA)CO and a 3D Val-HMCM(CBCA)CO were collected to link ILV methyl 
groups to C’. These methyl out-and-back experiments were found to be rather sensitive even for 
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this relatively large protein-bicelle system despite the pessimistic impression from limited 
studies reported in literature.  
 




C constant-time HMQC of the 














N] sample of EmrE-
S64V in complex with TPP
+
 at 45 ˚C was collected on a 800 MHz Varian spectrometer with a cryoprobe. The 
precursors used for labeling are shown: α-ketobutyrate is the precursor for Ile and α-ketoisovalerate is the precursor 
for Leu and Val. Two types of assignment experiments were used for methyl assignment: methyl-detected out-and-
back experiments where methyl groups are linked to Cβ/Cα/C’ and amide-detected experiments where methyl 
groups are linked to NH. Colors for the labeling: green, 
13
C; light grey, 
12









Fig. 3.14 Carbon chemical shift distributions for ILV residues and methyl out-and-back assignment experiments 
with different COSY transfer steps for the ILV sample of EmrE. The chemical shift distributions were from 
generated using CcpNmr Analysis
28
 with statistics from RefDB
41
. The methyl out-and-back experiments to correlate 
methyl groups to Cβ/Cα were shown in right with different COSY transfer steps (0 step, teal, HMQC; 1 step, purple, 
Cβ for Val and Cγ for Ile/Leu; 2 step, green, Cα for Val and Cβ for Ile/Leu; 3 step, navy, Cα for ILV with Cα for 
Val in negative sign and buried under 2 step plane).   
 
But the chemical shift dispersions in Cβ/Cα/C’ are still limited, since for a membrane protein 
system most of the ILV residues face lipids and experience very similar chemical environments. 
So we also collected the amide-detected assignment experiments which were much less 
sensitive, but worked unexpectedly well for this system and provided much better dispersion 
through the NH plane. A 3D Ile,Leu-(HM)CM(CGCBCA)NH and a 3D Val-










The matching of Cβ/Cα/C’ chemical shifts of this ILV sample to those of the uniformly 
deuterated sample was difficult. This was a result of the limited dispersion in the carbon 
dimension in membrane protein NMR and the multiple-bond deuterium isotope effect
42
. 
Therefore, we recollected backbone-walk data including a 3D TROSY-HNCA, a 3D TROSY-
HN(CA)CB, and a 3D TROSY-HNCO using this ILV sample.  
Besides these through-bond COSY-transfer type assignment experiments, several NOESY 
spectra including time-shared 3D C, N-HMQC-NOESY-TROSY and 3D C, N-HMQC-NOESY-
HMQC experiments were collected to help the assignment process.  
Using the above-mentioned comprehensive set of methyl assignment experiments, we were able 
to reach complete assignment of all 30 Ile-δ1 and 24 Val-γ methyl groups. For Leu, we have 
assigned 54 out of 64 methyl groups so far and the rest of Leu methyl assignment should be 
possible within a week.  
Our assignment for Ile δ1 methyl groups is supported by a recently published work where a 
series of Ile mutants were generated to assign the δ1 methyl group by recording carbon 2D 
spectra for each Ile-to-Leu mutant
43
. In that study, the chain assignment for these Ile methyl 
groups was achieved using a mixed dimer strategy where WT EmrE was mixed with I54L (or 
I62L), and the mutated monomer was found to prefer to stay in monomer A conformation. It is 
worth pointing out that our assignments are more complete than what is available from the 
mutagenesis work. Our NMR experiments also assigned peaks in the crowded regions and are 
less susceptible to potential global peak perturbations from mutation. So far, no methyl 
















Aromatic assignment For EmrE, aromatic groups are crucial to define the binding pocket of 
EmrE and protein-ligand interactions. This could be inferred even from the low-resolution 
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structure. The aromatic restraints were found to help pack TM helices in the NMR structure 
calculation of sensory rhodopsin II
10
. Thus we have invested major resources to facilitate 
aromatics assignment and restraints collection to improve the quality of final NMR structure. 
There are very limited studies for aromatic assignment, especially for large systems. Assignment 
experiment based on COSY transfer simply will not work as there are many transfer steps to 
reach already assigned resonances. This is further complicated by the large C-C coupling 
constants and large CSA of aromatic carbon. For aromatics, the assignment will be mainly 
structure-based
44
. We will rely on information from modeled structures (Fig. 3.17) and already 
assigned NH and methyl groups to facilitate aromatic assignment. 
 
Fig. 3.17 Contact analysis between EmrE-S64V and TPP
+
 from molecular dynamics simulations to facilitate 
structure-based aromatic assignment. The contribution of each amino acid to TPP
+
 binding was plotted when the 








N labeled sample (Fig. 
3.18). To improve both sensitivity and resolution for these aromatics, we have also tried alternate 
labeling where the large one-bond C-C coupling is eliminated and provides chances for aromatic 




 (Fig. 3.19) and are collecting 










N labeled EmrE-S64V in complex with TPP
+
 at 





Fig. 3.19 Carbon TROSY of the aromatic region using the 1-
13
C glucose labeling for EmrE-S64V in complex with 
TPP
+
 at 45˚C. The spectrum was acquired on a Varian 800 MHz spectrometer with a cryoprobe.  
 
Structural restraints I have already collected many structural restraints. The assigned backbone 
resonances were used to generate backbone dihedral angle restraints using TALOS-N, which will 
provide a major driving force for folding the primary sequence into helices. Alongside our 
assignment efforts, I have already collected a great deal of NOESY data. These include NOESY-
TROSY and NOESY-HSQC (for both carbon aromatics and aliphatics) for samples with 
different level of deuteration. We also have C,N-HMQC-NOESY-TROSY, C,N-HMQC-
NOESY-HMQC which contain hundreds of restraints related to ILV methyl groups.  
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Also we have used spectral filtering and editing to get protein-ligand NOE using the aromatic 
assignment sample to help define the binding pocket. The NOEs in these spectra are being 
assigned on the basis of the backbone and methyl assignments and the model structure in an 
iterative process by Claudia Cornilescu. 
In addition, I have also collected RDCs orientational restraints. RDCs contain information about 
bond orientations with respect to the common molecular frame, therefore RDCs provide long-
range restraints. Since the application to biomolecules, RDCs have been used to refine structures 
derived from either NOE or PRE distance restraints
5
. Here we have measured RDCs for NH and 
NC’ bond vectors. 
In order to measure RDCs, the protein should be slightly aligned to generate residual alignment 
of ~0.1%. Although most alignment media (including solvent-based systems, bicelles, and 
phage) do not work for membrane proteins due to their incompatibility with membrane-
mimetics, we show that 3.8% stretched acrylamide gel can be used to align the EmrE-bicelle 
system. The soaking method does produce high concentration samples. Due to the osmotic 
pressure of the high lipid concentration needed to solubilize EmrE, the protein to long-chain lipid 
ratio has been decreased to 1:50 from 1:100. Copolymerization method did not work because of 
the presence of detergent. However, polyacrylamide doped with charged derives was found to 
promote the swelling process, although the measured RDCs were degenerate with those from 
neutral gels. 
We tried both frequency-resolved methods and intensity-based methods to get precise 
measurements. Frequency-resolved experiments can directly measure the splitting as a result of 
residual alignment, but the number of peaks that can be measured is limited by the line shape of 
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the semi-TROSY peaks as some peaks will be broadened out due to the constructive relaxation 
of dipolar coupling and chemical shift anisotropy. Intensity-based methods use TROSY peaks 
primarily, and calculate RDCs from intensity ratios of a reference spectrum and an attenuated 
spectrum, therefore providing more precise measurements for large systems like EmrE in a 
bicelle. For both NH and NC’ RDCs measurement, we have used intensity-based methods. The 
NH RDCs were measured using the ARTSY pulse sequence
33
 and we have over 100 high quality 
orientational restraints for S64V-EmrE system (Fig. 3.19). The NC’ RDCs measurements proved 
to be much more difficult as a result of the much smaller coupling constants. We got dozens of 
useful restraints using an intensity modulation method
34
 primarily in loops where lack of regular 
secondary structure makes these restraints particular useful. 
 
Fig. 3.20 RDCs for amide bond vectors for TPP
+
-bound EmrE-S64V collected on a Varian 700 MHz spectrometer 
with a room temperature probe. The aligned condition was achieved using 3.8% neutral acrylamide gel.  

























A better structure of EmrE offers the opportunity for new insight into the multidrug transport 
mechanism. The conformational plasticity of EmrE, while essential for its function, makes NMR 
the best structural approach to obtain a better structure. However, NMR structure determination 
of a membrane transporter with eight unique transmembrane helices is highly challenging. Here 
we have made significant progress towards a better structure of EmrE using a mutant with 
reduced dynamics. Using the most recent cutting-edge NMR developments, we have achieved a 
near complete backbone assignment and side chain methyl assignment. We have also collected a 
great deal of structural restraints including NOEs and RDCs. Future integration of these NMR 
data and modeling studies for final structural calculation hold great promise for a better structure 
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and analyzed most of the data. Marco Tonelli was responsible for all pulse sequence testing and 
data collection at NMRFAM. Dr. Gregory T. DeKoster helped with local pulse sequence testing 
and labeling strategies for side chain assignment. Dr. Eva-Maria Uhlemann tested pyruvate 
labeling scheme and prepared samples for aromatic labeling. Dr. Katherine A. Henzler-Wildman 
and Dr. Claudia C. Cornilescu contributed to the assignment. Josh V. Vermaas from Dr. Emad 
84 
 
Tajkhorshid lab did the molecular modeling work. The deuterated TPP
+
 was synthesized in Dr. 
Jim Davis lab. Chao Wu did the writing and Dr. Katherine A. Henzler-Wildman revised it. 
 
References 
1 Wüthrich, K. The way to NMR structures of proteins. Nature structural biology 8, 923-
925, doi:10.1038/nsb1101-923 (2001). 
2 Simpson, P. J. in Nuclear Magnetic Resonance: Volume 44 Vol. 44    348-384 (The 
Royal Society of Chemistry, 2015). 
3 Kwan, A. H., Mobli, M., Gooley, P. R., King, G. F. & Mackay, J. P. Macromolecular 
NMR spectroscopy for the non-spectroscopist. The FEBS journal 278, 687-703, 
doi:10.1111/j.1742-4658.2011.08004.x (2011). 
4 Shen, Y. & Bax, A. Protein backbone and sidechain torsion angles predicted from NMR 
chemical shifts using artificial neural networks. Journal of biomolecular NMR 56, 227-
241, doi:10.1007/s10858-013-9741-y (2013). 
5 Bax, A. & Grishaev, A. Weak alignment NMR: a hawk-eyed view of biomolecular 
structure. Current opinion in structural biology 15, 563-570, 
doi:10.1016/j.sbi.2005.08.006 (2005). 
6 Rosenzweig, R. & Kay, L. E. Bringing dynamic molecular machines into focus by 
methyl-TROSY NMR. Annual review of biochemistry 83, 291-315, doi:10.1146/annurev-
biochem-060713-035829 (2014). 
7 Vitali, T. & Lewis, E. K. Ile, Leu, and Val Methyl Assignments of the 723-Residue 
Malate Synthase G Using a New Labeling Strategy and Novel NMR Methods. Journal of 
the American Chemical Society 125, 1386813878, doi:10.1021/ja030345s (2003). 
85 
 
8 Cross, T. A., Ekanayake, V., Paulino, J. & Wright, A. Solid state NMR: The essential 
technology for helical membrane protein structural characterization. Journal of magnetic 
resonance (San Diego, Calif. : 1997) 239, 100-109, doi:10.1016/j.jmr.2013.12.006 
(2014). 
9 Murray, D. T., Das, N. & Cross, T. A. Solid state NMR strategy for characterizing native 
membrane protein structures. Accounts of chemical research 46, 2172-2181, 
doi:10.1021/ar3003442 (2013). 
10 Gautier, A., Mott, H. R., Bostock, M. J., Kirkpatrick, J. P. & Nietlispach, D. Structure 
determination of the seven-helix transmembrane receptor sensory rhodopsin II by 
solution NMR spectroscopy. Nature structural & molecular biology 17, 768-774, 
doi:10.1038/nsmb.1807 (2010). 
11 Park, S. H. et al. Structure of the chemokine receptor CXCR1 in phospholipid bilayers. 
Nature 491, 779-783, doi:10.1038/nature11580 (2012). 
12 Wang, S. et al. Solid-state NMR spectroscopy structure determination of a lipid-
embedded heptahelical membrane protein. Nature methods 10, 1007-1012, 
doi:10.1038/nmeth.2635 (2013). 
13 Reckel, S. et al. Solution NMR structure of proteorhodopsin. Angewandte Chemie 
(International ed. in English) 50, 11942-11946, doi:10.1002/anie.201105648 (2011). 
14 Berardi, M. J., Shih, W. M., Harrison, S. C. & Chou, J. J. Mitochondrial uncoupling 
protein 2 structure determined by NMR molecular fragment searching. Nature 476, 109-
113, doi:10.1038/nature10257 (2011). 
15 Morrison, E. et al. Antiparallel EmrE exports drugs by exchanging between asymmetric 
structures. Nature 481, 45-50, doi:10.1038/nature10703 (2012). 
86 
 
16 Morrison, E. & Henzler-Wildman, K. Reconstitution of integral membrane proteins into 
isotropic bicelles with improved sample stability and expanded lipid composition profile. 
Biochimica et biophysica acta 1818, 814-820, doi:10.1016/j.bbamem.2011.12.020 
(2012). 
17 Morrison, E. A. & Henzler-Wildman, K. A. Transported substrate determines exchange 
rate in the multidrug resistance transporter EmrE. The Journal of biological chemistry 
289, 6825-6836, doi:10.1074/jbc.M113.535328 (2014). 
18 Qing, G. et al. Cold-shock induced high-yield protein production in Escherichia coli. 
Nature biotechnology 22, 877-882, doi:10.1038/nbt984 (2004). 
19 Kelly, A. E., Ou, H. D., Withers, R. & Dötsch, V. Low-conductivity buffers for high-
sensitivity NMR measurements. Journal of the American Chemical Society 124, 12013-
12019, doi:10.1021/ja026121b (2002). 
20 Dutta, S., Morrison, E. A. & Henzler-Wildman, K. A. EmrE dimerization depends on 
membrane environment. Biochimica et biophysica acta 1838, 1817-1822, 
doi:10.1016/j.bbamem.2014.03.013 (2014). 
21 Morrison, E. A., Robinson, A. E., Liu, Y. & Henzler-Wildman, K. A. Asymmetric 
protonation of EmrE. The Journal of general physiology 146, 445-461, 
doi:10.1085/jgp.201511404 (2015). 
22 Takeuchi, K., Ng, E., Malia, T. & Wagner, G. 1-13C amino acid selective labeling in a 
2H15N background for NMR studies of large proteins. Journal of biomolecular NMR 38, 
89-98, doi:10.1007/s10858-007-9152-z (2007). 
87 
 
23 Renee, O., Byron, C., Karla, D. K., Hans, J. V. & Frans, A. A. M. Comprehensive and 
cost-effective NMR spectroscopy of methyl groups in large proteins. Journal of the 
American Chemical Society 132, 2952-2960, doi:10.1021/ja907706a (2010). 
24 Lundström, P. et al. Fractional 13C enrichment of isolated carbons using [1-13C]- or [2-
13C]-glucose facilitates the accurate measurement of dynamics at backbone Cα and side-
chain methyl positions in proteins. Journal of Biomolecular NMR, doi:10.1007/s10858-
007-9158-6 (2007). 
25 Milbradt, A. G. et al. Increased resolution of aromatic cross peaks using alternate 13C 
labeling and TROSY. Journal of biomolecular NMR 62, 291-301, doi:10.1007/s10858-
015-9944-5 (2015). 
26 Chou, J. J., Gaemers, S., Howder, B., Louis, J. M. & Bax, A. A simple apparatus for 
generating stretched polyacrylamide gels, yielding uniform alignment of proteins and 
detergent micelles. Journal of biomolecular NMR 21, 377-382 (2001). 
27 Delaglio, F. et al. NMRPipe: A multidimensional spectral processing system based on 
UNIX pipes. Journal of Biomolecular NMR 6, 277-293, doi:10.1007/bf00197809 (1995). 
28 Vranken, W. F. et al. The CCPN data model for NMR spectroscopy: development of a 
software pipeline. Proteins 59, 687-696, doi:10.1002/prot.20449 (2005). 
29 Hyberts, S. G., Arthanari, H. & Wagner, G. Applications of non-uniform sampling and 
processing. Topics in current chemistry 316, 125-148, doi:10.1007/128_2011_187 
(2012). 
30 Hyberts, S. G., Takeuchi, K. & Wagner, G. Poisson-gap sampling and forward maximum 
entropy reconstruction for enhancing the resolution and sensitivity of protein NMR data. 
88 
 
Journal of the American Chemical Society 132, 2145-2147, doi:10.1021/ja908004w 
(2010). 
31 Hyberts, S. G., Milbradt, A. G., Wagner, A. B., Arthanari, H. & Wagner, G. Application 
of iterative soft thresholding for fast reconstruction of NMR data non-uniformly sampled 
with multidimensional Poisson Gap scheduling. Journal of biomolecular NMR 52, 315-
327, doi:10.1007/s10858-012-9611-z (2012). 
32 Sun, S., Gill, M., Li, Y., Huang, M. & Byrd, R. A. Efficient and generalized processing 
of multidimensional NUS NMR data: the NESTA algorithm and comparison of 
regularization terms. Journal of biomolecular NMR 62, 105-117, doi:10.1007/s10858-
015-9923-x (2015). 
33 Nicholas, C. F. & Ad, B. Facile measurement of ¹H-¹
5
N residual dipolar couplings in 
larger perdeuterated proteins. Journal of biomolecular NMR 48, 65-70, 
doi:10.1007/s10858-010-9441-9 (2010). 
34 Liu, Y. & Prestegard, J. H. Measurement of one and two bond N-C couplings in large 
proteins by TROSY-based J-modulation experiments. Journal of magnetic resonance 
(San Diego, Calif. : 1997) 200, 109-118, doi:10.1016/j.jmr.2009.06.010 (2009). 
35 Sousa da Silva, A. W. & Vranken, W. F. ACPYPE - AnteChamber PYthon Parser 
interfacE. BMC Research Notes 5, 1-8, doi:10.1186/1756-0500-5-367 (2012). 
36 Trabuco, L. G., Villa, E., Mitra, K., Frank, J. & Schulten, K. Flexible fitting of atomic 
structures into electron microscopy maps using molecular dynamics. Structure (London, 
England : 1993) 16, 673-683, doi:10.1016/j.str.2008.03.005 (2008). 
37 Trabuco, L. G., Villa, E., Schreiner, E., Harrison, C. B. & Schulten, K. Molecular 
dynamics flexible fitting: a practical guide to combine cryo-electron microscopy and X-
89 
 
ray crystallography. Methods (San Diego, Calif.) 49, 174-180, 
doi:10.1016/j.ymeth.2009.04.005 (2009). 
38 Trabuco, L. G. et al. Applications of the molecular dynamics flexible fitting method. 
Journal of structural biology 173, 420-427, doi:10.1016/j.jsb.2010.09.024 (2011). 
39 Bezanilla, F. How membrane proteins sense voltage. How membrane proteins sense 
voltage, doi:10.1038/nrm2376 (2008). 
40 Tugarinov, V., Kanelis, V. & Kay, L. E. Isotope labeling strategies for the study of high-
molecular-weight proteins by solution NMR spectroscopy. Nature protocols 1, 749-754, 
doi:10.1038/nprot.2006.101 (2006). 
41 Zhang, H., Neal, S. & Wishart, D. S. RefDB: A database of uniformly referenced protein 
chemical shifts. Journal of Biomolecular NMR 25, 173-195, 
doi:10.1023/a:1022836027055. 
42 Gardner, K. H. & Kay, L. E. The use of 2H, 13C, 15N multidimensional NMR to study 
the structure and dynamics of proteins. Annual review of biophysics and biomolecular 
structure 27, 357-406, doi:10.1146/annurev.biophys.27.1.357 (1998). 
43 Gayen, A., Leninger, M. & Traaseth, N. J. Protonation of a glutamate residue modulates 
the dynamics of the drug transporter EmrE. Nature chemical biology, 
doi:10.1038/nchembio.1999 (2016). 
44 Hagn, F. & Wagner, G. Structure refinement and membrane positioning of selectively 
labeled OmpX in phospholipid nanodiscs. Journal of biomolecular NMR 61, 249-260, 
doi:10.1007/s10858-014-9883-6 (2015). 
45 Lundström, P. et al. Fractional 13C enrichment of isolated carbons using [1-13C]- or [2- 
13C]-glucose facilitates the accurate measurement of dynamics at backbone Calpha and 
90 
 






Chapter 4: Transmembrane Helix Kinking in 
Conformational Interconversion of EmrE 
Abstract 
Transmembrane helix kinks are relatively common structural features of integral membrane 
proteins such as transporters, channels, and GPCRs. These kinks are often found in functionally 
important sites and act as hinges of the structural fold, which enable proteins to sample different 
conformational states required by their functions. In the small multidrug resistance transporter, 
EmrE, there is a kink in TM3 of one monomer but not the other in the asymmetric homodimer 
structure. Due to the way EmrE interconverts between open-in and open-out states, the kinking 
and unkinking of TM3 is likely central to the whole transport cycle. Understanding this 
mechanism will provide insight into the physical basis of the multidrug transport process.  
Here I perturb the TM3 kink region using a series of mutants and ligands, and measure the 
interconversion rates for these systems using NMR. I find that mutations around the kink region 
at position 64 can dramatically alter the interconversion rates over several orders of magnitude. 
Dynamics data from both the mutants and the ligand series reveal the importance of 
hydrophobicity in determining the conformational interconversion rate, and support the idea that 
hydration around the kink region is very important for determining the rate of TM3 kinking and 
the conformational interconversion necessary for transport. This is reasonable, since backbone 
hydrogen bonds must break to form the kink and the energetics will depend on the effective 
dielectric constant in this area. This slow-down as a result of S64V mutation is even more 
dramatic in the absence of drug. The S64V mutation slows the conformational interconversion of 






 (S64V mutant). This same mutation also raises 
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the pKa of E14, the critical residue for coupling proton import to drug export. Thus, these results 
suggest the novel hypothesis that hydration provides the physiochemical basis linking proton 
import and drug export, as required for proton-coupled antiport. 
 
Introduction 
A common feature in helical membrane proteins is that transmembrane helices (TM) are 
frequently kinked
1-6
. These kinks usually locate at sites of functional importance as they provide 
exposed helix dipoles for specific ligand binding and increase structural complexities needed for 
diverse functions within a general fold space. In addition, these kinks act as hinge points to 
facilitate conformational sampling needed for functions. 
In the small multidrug resistance transport, EmrE, there is a kink in TM3 that has been 
increasingly recognized as important for the conformational interconversion and multidrug 
recognition
7-10
. During the construction of the cryoEM model based on the electron map and 
sequence conservation within the Small Multidrug Resistance transporter family, a kink was 
located in TM3 of monomer A in the asymmetric dimer of EmrE
7
. This kink in TM3 was found 
to be important for the conformational plasticity of EmrE, facilitating its recognition of drugs of 
different shapes and charges
8
. This kink is also crucial to the conformational interconversion 
process central to alternating-access transport based on solid- and solution-state NMR studies
9-11
. 
Intrigued by the location of S64V mutation, the only slow dynamics mutation identified in our 
screening efforts, we set out to characterize a series of EmrE S64 mutants to probe the 




Materials and methods 
Sample preparation WT and mutant EmrE were expressed, purified, and reconstituted into 
isotropic bicelles as previously described
9,11,12
. Single point mutants were constructed using 
QuickChange Mutagenesis (Stratagene). 
In-cell transport assay These assays were carried out using the BL21(DE3) strain of E. coli 
transformed with empty pET15b vector or pET15b containing WT or mutant EmrE. The cells 
were grown in M9 minimal media with 100 μg/ml of ampicillin at 37 ˚C until the OD600 reached 
0.4. Then cells were induced with 0.33 mM isopropyl 1-thio-β-D-galactopyranoside (IPTG) for 
30 minutes at 37˚C. 2.5 μM ethidium bromide and 40 μM carbonyl cyanide p-
chlorophenylhydrazone (CCCP) were added and the cells were incubated at 37˚C for an 
additional hour. Assays were started immediately with excess cell culture stored on ice until it 
was in an assay. For each experiment, 2 ml of cell culture was spun down and immediately 
resuspended in 1 ml fresh M9 media with 2.5 μM ethidium bromide. Ethidium bromide 
fluorescence was monitored with excitation at 545 nm and emission at 610 nm. The time course 
of fluorescence was plotted after normalization to the initial value of each run. 
Isothermal titration calorimetry All isothermal titration calorimetry (ITC) experiments were 
performed on a TA instruments LV Nano calorimeter. Data were fit simultaneously to a model of 
ligand binding to n independent and identical sites plus a constant baseline due to mixing
11
. All 
ITC experiments were performed at least in triplicate. EmrE was reconstituted into 
DMPC/DHPC (q = 0.33) isotropic bicelles in 20 mM potassium phosphate, 20 mM NaCl, pH 7, 
45 ºC and loaded into the cell at 40-60 μM for tetraphenylphophonium (TPP
+
) titrations and 500 
μM for titration with methyltriphenylphophonium (MeTPP
+












concentrations were 2-4 mM. For these two weaker ligands, only duplicates were carried out, 
therefore, the reported errors are standard error of mean (SEM). All solutions contained buffer 
and bicelle concentrations matched to the protein samples. 




N EmrE in DMPC/DHPC bicelles (q = 0.33, with a protein to DMPC molar ratio of 1:50) 
and 100 mM MOPS, 10-30 mM NaCl, 2 mM TCEP, 8-10 % D2O, pH 7 at 45 ˚C on a Varian 700 
MHz spectrometer with a room temperature probe unless otherwise noted. All NMR spectra 
were processed with NMRPipe
13
 and analyzed in CcpNmr Analysis
14
. For the TPP
+
-bound 
EmrE, 2 mM TPP
+
 was added to ensure EmrE saturation. For EmrE-S64V in complex with 
weaker ligands, 10 mM MeTPP
+
 or 5 mM EtTPP
+





HSQC and TROSY-selected ZZ-exchange experiments
15
 with a lipid flip-back pulse
9
 were 
carried out with a recycle delay of 2 s and 128-144 increments. The conformational 
interconversion rate, kconf, were analyzed from the ZZ-exchange data as previously described
16
 
using the composite peak ratio method with an 11.1 ms offset time, t0, to account for the back-
transfer time in the pulse sequence
11
. The composite peak ratios of intensities of the auto-peaks 






2 (𝑡 − 𝑡0)
2.  (1) 
For TPP
+
 bound EmrE, two planes were collected with different mixing times and the mixing 
times were adjusted according to the conformational interconversion rate of each mutant. The 
mixing times were 40, 60 ms for S64A, 100, 200 ms for S64T, and 200, 225 ms for S64V. For 
S64V bound to weaker ligands, the mixing times were 40, 60, 80, 100 ms for MeTPP
+
 and 80, 
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120, 160, 180 ms for EtTPP
+
. The standard deviation of individual fits was used to estimate the 
error of the rates.  
pH titrations of S64V drug-free EmrE were performed on a Varian 800 MHz spectrometer with a 
cryoprobe using a sample prepared as described above except that ether-linked DHPC (eDHPC) 
was substituted for the standard ester-linked DHPC in the bicelles. The ether-linked lipid is more 
pH stable, so this substitution reduces pH drift in higher pH-samples that normally occur as a 
result of lipid hydrolysis. The DMPC was not substituted to minimize the perturbation to the 
protein
17
. To span a wide range of pH, a mixed buffer system was used with 50 mM boric acid, 
50 mM bicine, 50 mM MOPS, and 20 mM acetate. The buffer system and eDHPC were 
observed to have minimal effect on the NMR spectra and interconversion rates of EmrE. For the 
S64V drug-free system, a single ZZ plane with a 200 ms mixing time was collected at each pH 
condition to estimate the interconversion rate. As a result of the increased solvent exchange, only 
limited cross peaks could be observed at the long mixing times required to monitor exchange in 
this mutant. For the pH titration data, amide proton and nitrogen chemical shifts were fit 
separately
18
 to either one or two pKa values using the following equations
19,20
. For the single pKa 
model, the generalized Henderson-Hasselbalch equation was used to describe the chemical shift 
of each residue, δ, as a function of pH: 





,     (2) 
where δP and δD are the chemical shift of the protonated and deprotonated state of the residue. 
For the two pKa model, a generalized macroscopic model was used:   






,  (3) 
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where δP and δD are the chemical shifts of the fully protonated and deprotonated state of the 
residue, and δI is chemical shift of the intermediate singly protonated species. 
 
Results 
EmrE-S64V is a kink region slow dynamics mutant that maintains multidrug binding. From 
our previous screening efforts to find dynamics mutants of EmrE suitable for structural studies, 
we identified EmrE-S64V as a slow dynamics mutant. As can be seen from ethidium efflux assay 
data in E. coli (Fig. 4.1), this mutation significantly impairs EmrE transport activity in its native 
environment, although it still export ethidium faster than the negative control. There are several 
possible origins of this behavior: impaired substrate binding, leaking or uncoupling of the 
transporter due to loss of proper structure, or reduced conformational interconversion rates 




Fig. 4.1 Normalized fluorescence as a function of time from in-cell assay for EmrE-S64V. Data from the black curve 
were collected for E. coli cells transformed with empty pET15b vectors whereas data from the red and blue curve 
were from cells with EmrE overexpression.  
 
This impaired transport by S64V-EmrE is mostly likely not due to impaired ligand binding since 
the screening process that identified this mutation selected against mutants that did not bind 
ligand. I performed more quantitative binding assays to confirm this. Ethidium is a weak binding 
ligand and the Kd is difficult to precisely determine. However, as determined by isothermal 









, EmrE-S64V has very similar ligand binding properties compared to WT EmrE in 
general. These TPP
+
 derivatives were shown to have very interesting properties: both their 
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affinities to EmrE and the interconversion rates of EmrE bound to these ligands vary over two 
orders of magnitude
11
. Based on these results, it seems unlikely that the reduced ethidium export 
of EmrE-S64V would arise from significantly altered ligand binding. In addition, these data 
demonstrate that EmrE-S64V maintains the multidrug binding capability. 
 






. These ligands 
differ in only one of the four phenyl rings. These experiments were performed at pH 7, 45 ˚C in DMPC/DHPC (q = 
0.33) bicelles. The first data points of these titrations were omitted for fitting since it was an artifact from titrant 
dilution during incubation. As a comparison, for WT EmrE in DLPC/DHPC bicelles
11







 are 0.45 ± 0.01, 21.8 ± 0.7, and 130 ± 20 μM. 
 
The TROSY-HSQC spectrum (Fig. 4.3) of EmrE-S64V in complex with TPP
+
 is strikingly 
similar to TPP
+
-bound WT EmrE, with two sets of peaks that is characteristic of the asymmetric 
dimer structure. Thus, EmrE-S64V in complex with TPP
+
 remains an asymmetric dimer structure 
99 
 
with an overall structure that must be quite similar to WT. There are global peak shifts in the 
vicinity of the mutation, as well as some more remote chemical shift changes as a result of the 
altered kink region. As observed for the WT EmrE, the TROSY-HSQC spectra of EmrE-S64V in 
complex with TPP
+
 are also very similar in DLPC/DHPC and DMPC/DHPC bicelles confirming 
that EmrE is relatively structurally insensitive to the thickness of the lipid bilayer. However, the 
conformational interconversion rate between open-in and open-out drug-bound states is 
significantly different. Whereas WT EmrE in complex with TPP
+
 interconverts at a rate of 4.7 ± 
0.6 (4.4 ± 0.4) s
-1
 in DMPC/DHPC (DLPC/DHPC) bicelles, EmrE-S64V in complex with TPP
+
 
has a conformational rate of 0.6 ± 0.1 (1.2 ± 0.2) s
-1
 in DMPC/DHPC (DLPC/DHPC) bicelles. 
This data clearly shows that EmrE-S64V is a slow-dynamics mutant and that altered 
conformational interconversion dynamics is the most likely cause of the reduced ethidium efflux 




Fig. 4.3 TROSY-HSQC and ZZ-exchange spectra for EmrE in complex with TPP
+
 at pH 7, 45 ˚C in bicelles (q = 
0.33). A. TROSY-HSQC overlay for WT (black) and S64V (red) in DLPC/DHPC bicelles. B. TROSY-HSQC 
overlay for S64V in DLPC (red) and DMPC (green). C. Overlay of TROSY-HSQC (red) and a ZZ plane with 200 
ms mixing time (blue) for S64V in DLPC/DHPC bicelles. D. Overlay of TROSY-HSQC (green) and a ZZ plane 
with 200 ms mixing time (blue) for S64V in DMPC/DHPC bicelles. Dotted boxes in C. and D. connect auto- and 
cross-peaks of pairs of amides that correspond to the same residue in each monomer and the exchange peaks due to 
the two monomers swapping conformations as EmrE interconverts between open-in and open-out. From the ZZ 
data, the conformational interconversion rates of EmrE-S64V in complex with TPP
+
 are 0.6 ± 0.1 s
-1
 in 
DMPC/DHPC bicelles and 1.2 ± 0.2 s
-1
 in DLPC/DHPC bicelles. As a comparison, the rates for WT EmrE in 
complex with TPP
+
 are 4.7 ± 0.6 s
-1
 in DMPC/DHPC bicelles and 4.4 ± 0.4 s
-1




Characterization of S64 mutant series Our previous screening efforts for putative dynamics 
mutants (Chapter 2) revealed that most of the mutations that led to impaired transport activity, 
actually increased the conformational interconversion rate. S64V mutation was the only mutation 
consistent with our initial hypothesis. The position of Ser64 in TM3 is quite interesting due to its 
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 which is 
known to introduce a kink in TM3 of EmrE. From the cryoEM structure, this kink is only found 
in monomer A
7
 and is shown to contribute to the plasticity of the drug binding site of EmrE, 
which is important for multidrug recognition
8
. The difference in helix kinking between the two 
TM3 in the dimer was also observed using oriented solid state NMR
10
. Also chemical shift 
difference mapping from solution NMR data highlights the TM3 kink region as the most distinct 
in each monomer of the asymmetric dimer
9
 and also one of the most sensitive regions to identity 
of the bound ligand
11
. The medium resolution X-ray and cryoEM structures
7,22
 both suggest that 
the polar Ser64 residues from both monomers are facing inside and forming interhelix contacts, 
consistent with a functional role in conformational interconversion process. In addition, Ser64 is 
right after Trp63 which is one of the most conserved residues in its polyaromatic cation binding 
and critical for determining the substrate specificity of the transporter
23
.  Thus, the residue at 
position 64 may also be critical for linking drug binding to transport. Sequence conservation 
data
21
 suggests that there are three other frequently occurring residues at this position: Thr, Ala, 
and Val. I further characterized these EmrE S64 mutants to probe the conformational 
interconversion mechanism. I also included S64A and S64L mutations to get more 




Fig. 4.4 Characterization of EmrE S64 mutants. A. Sequence logo for TM3 of EmrE. Figure was modified from 
Elbaz et. al., 2008
21
. Colors: green, polar; blue, basic; red, acidic; black, hydrophobic. B. Normalized fluorescence 
as a function of time for EmrE WT and S64 mutants from in-cell assay data. Data from the black curve were 
collected for E. coli cells transformed with empty pET15b vectors whereas data from the others were from cells with 
EmrE overexpression. WT, red; S64G, olive; S64A, navy; S64T, magenta; S64V, blue; S64L, purple. C. Measured 
Kd for EmrE WT and S64 mutants with the ligand TPP
+
 from ITC and conformational interconversion rates, kconf, 
from ZZ-exchange experiments. Numbers in parentheses are standard deviations. D. TROSY-HSQC spectra for 
EmrE in complex with TPP
+
, in DMPC/DHPC bicelles at pH 7, 45˚C, for WT (red), S64A (navy), S64T (magenta), 
and S64V (blue) show two sets of peaks. E. TROSY-HSQC spectra for EmrE in complex with TPP
+
 for S64G 
(olive) and S64L (purple) show only one set of peaks suggesting significantly faster conformational interconversion. 
 
The in-cell transport assay data provides a quick overview of the ethidium bromide export 
properties of cells expressing the different EmrE mutants (Fig. 4.4 B). Not surprisingly, cells 
expressing WT EmrE export ethidium bromide most efficiently followed by the S64G and S64A 
mutants. Cells expressing S64T-EmrE behave differently and are more transport-impaired in the 
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initial stage. Cells with the two largest and most hydrophobic mutations at this site, S64V-EmrE 
and S64L-EmrE, behave similarly and are the most transport-impaired. These in vivo drug export 
data are interesting but only provide a rather qualitative picture about the behavior of cells 
expressing EmrE. Factors like different expression, folding, and insertion levels of the various 
EmrE mutants would require many additional controls to seriously compare the drug export 
properties of these EmrE mutants.  
I went on to characterize TPP
+
 binding affinities of this series of EmrE mutants using ITC to 
more quantitatively evaluate differences in ligand binding properties (Fig. 4.4 C). Interestingly, 
the measured Kd values for these EmrE mutants binding to TPP
+ 
vary only slightly; all the Kd 
values fall between 200-1450 nM under identical conditions. These similar drug affinities among 
the various S64 mutants, along with the similarity between the binding affinities of S64V- and 
WT-EmrE for different TPP
+
 derivatives, collectively suggest that the binding site of EmrE is 
fairly plastic and perturbations to either ligands or proteins can be accommodated without loss of 
affinity. Thus defects in ligand binding unlikely contribute to the observed different phenotypes.  
Intrigued by the distinct phenotypes of different S64 mutations on the drug export function of 
EmrE, we characterized these TM3 kink mutants using solution NMR to identify possible 
dynamics-function correlations. As shown in the TROSY-HSQC spectra (Fig. 4.4 D,E) of EmrE 
in complex with TPP
+
, WT EmrE and S64A-, S64T-, and S64V-EmrE all show two sets of peaks 
corresponding to the asymmetric dimer. These mutations do not change the structure 
dramatically. In the case of EmrE S64A, cross-peaks due to conformational interconversion 
appear in the TROSY-HSQC spectrum indicating faster interconversion between open-in and 
open-out for this mutant, on the order of 30-100 s
-1
. In the case of S64G-EmrE bound to TPP
+
, 
the conformational interconversion is so fast that only one set of peaks appear in the spectrum. 
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This is similar to WT EmrE bound to MeTPP
+
, and a rough estimate of the rate suggests that the 
conformational interconversion should be faster than 100 s
-1
 for S64G-EmrE in complex with 
TPP
+
. Glycine residues in transmembrane helices are known to render the helices more flexible 
as a result of the larger conformational space that can be sampled by glycine backbone dihedral 
angles. Therefore glycine is one of the two residues that are known to cause kinks in helices. In 
light of this, the increased dynamics by the S64G mutation of EmrE (which results in a GGVG 
sequence in the TM3 kink region) makes sense. Using ZZ-exchange experiments, we calculated 
that the rates for mutants that still had two sets of peaks in the spectrum. The interconversion 
rates for S64A and S64T are 28 ± 3 and 2.1 ± 0.3 s
-1
. Thus, within the mutation series, as the size 
of the residue 64 in EmrE gets larger, the interconversion rates for TPP
+
-bound state decrease. 
However, this trend does not hold for the S64L mutation. Like S64G-EmrE, the spectrum for 
S64L-EmrE in complex with TPP
+
 has only one set of peaks and significant line broadening 
suggesting significantly faster dynamics or loss of structural asymmetry or stability. Thus, 
although S64L behaves similarly to S64V in the in-cell ethidium efflux assay, its behavior is 
quite distinct based on the NMR dynamics data. One possible explanation is that the bulky side 
chain of S64L (Leu is rare at this position in the SMR family) might not fit within the tightly 
packed helix-helix interface where S64 is located and may disrupt the structure of this critical 
region more generally. As pointed out previously, the conformational interconversion step is 
only one of the potential rate-limiting steps in the transport cycle
11
 and S64L may disrupt other 
aspects of the transport cycle, such as proton coupling.  
Hydration around the kink region in conformational interconversion A closer look into the 
thermodynamic components of different EmrE mutants binding to TPP
+
 reveals the importance 





not change much for different S64 mutants of EmrE. However, the enthalpic and entropic 
components differ significantly (Fig. 4.5 A). For S64G/A/T substitutions, both ΔH and –TΔS of 
TPP
+
 binding vary but remain negative as for WT EmrE. However, for S64V/L substitutions, ΔS 
is positive. This observed enthalpy-entropy compensation
24-31
, is almost universally observed in 
weak interactions in water. This suggests that the different S64 mutants may result in distinct 
hydration patterns around the TM3 kink region. Altered hydration in this region would affect the 
conformational interconversion rate because TM3 is only bent in one monomer of the 
asymmetric dimer. As EmrE interconverts between open-in and open-out states, kinking and 
unkinking must occur as the two monomers swap conformations within the asymmetric dimer. 
This requires breaking and rebuilding of backbone hydrogen bonds near the middle of TM3, 
which is likely a relatively hydrophobic environment. Altered hydration patterns will change the 




The idea that hydration around TM3 kink region may be important for conformational 
interconversion is supported when comparing interconversion rates of the closely related TPP
+
 
derivatives (Fig. 4.5 B,C). Previously, dynamics studies
11
 using this series of TPP
+
 derivatives 
revealed that the interconversion rate decreases as the ligand becomes larger and more 
hydrophobic. This is true all the way from the smallest ligand, MeTPP
+
 (130 ± 20 s
-1
, in 
DLPC/DHPC bicelles), to EtTPP
+
 (21.8 ± 0.7 s
-1
, in DLPC/DHPC bicelles), to TPP
+
 (4.4 ± 0.4 s
-
1
, in DLPC/DHPC bicelles; 4.7 ± 0.6 s
-1
, in DMPC/DHPC bicelles), and to the largest, DPhTPP
+
 
(0.4 ± 0.1 s
-1
, in DLPC/DHPC bicelles). These could be understood using the hydration concept: 
as the ligand gets bigger and more hydrophobic, it blocks water access into the transport pore 
and the TM3 kink region becomes dehydrated increasing the energetic barrier of helix kinking 
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and leading to slower interconversion. This trend is also observed in S64V-EmrE with the 













 (I did not measure the interconversion rate for EmrE-S64V in 
complex with DPhTPP
+
 as that would require prohibitively long mixing times for ZZ-exchange 
experiments). Interestingly, the calculated ratios of interconversion rates from ligand and protein 
perturbations (Fig. 4.5 D) further suggest there is a shared dehydration process. For example, in 













. However, the ratio is 









, the ratios are ~16 and ~20 when the protein is perturbed from Ser 
to Val. The ratio drops significantly for TPP
+
 and is now ~8. These results lead to a shared 
dehydration hydration hypothesis: increasing either ligand or protein hydrophobicity in the 
transport pore near the TM3 kink will dehydrate the binding site, reduce the rate of 
conformational interconversion, and reduce the rate of drug efflux. However, a limit is reached 





Fig. 4.5 The role of hydration in proton-driven drug efflux by EmrE. A. Enthalpy-entropy compensation in TPP
+
 







 (green) show no major structural changes. C. Conformational 
interconversion rates, kconf, for WT- and S64V-EmrE in the presence and absence of drug. The rates for WT EmrE in 
drug-free state were estimated from solid-state NMR PUREX experiments
34
 and our own ZZ-exchange 
measurements of drug-free EmrE
20
. The rates for EmrE S64V in drug-free state were estimated from ZZ-exchange 
data although the slow rate limits the number of cross peaks that can be quantified. D. Ratios of conformational 
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interconversion rates as a result of perturbation to the protein and the bound ligand. WT EmrE systems are colored 
in red while EmrE-S64V systems are colored in blue. Numbers in parentheses are propagated errors in ratios. E. A 
cartoon model to explain the role of hydration around kink region affects helix kinking and unkinking in 
conformational interconversion. The two TM3 helices in the antiparallel asymmetric dimer are drawn in yellow 
while the rest of EmrE is shown as green blob. During conformational interconversion, one TM3 kinks and the other 
straightens. When the position 64 is a serine residue, there are more water molecules around the kink effectively 
lowering the energetic barrier for helix kinking and unkinking. 
 
As the saturation trend in our ligand and protein perturbation series suggests a shared 
dehydration process, we predicted that the differences in interconversion rates between WT and 
S64V EmrE will be even larger in the drug-free state. This is because the substitution of the 
serine with valine should displace more waters than that when the binding site is already 
occupied by a large hydrophobic ligand. This prediction is borne out by comparison of the 
interconversion rates between drug-free WT- and S64V-EmrE (Fig. 4.5 C). The interconversion 
rate determined from solid-state NMR
34
 for WT EmrE in aligned DMPC/DHPC bicelles is over 
100 s
-1
 below neutral pH at 37˚C. This is consistent with rates determined from solution NMR in 
bicelles at 45 ˚C of ~50 s
-1
 at pH 8.8, ~75 s
-1
 at pH 8.4, and much faster (>100 s
-1
) at lower pH 
values
20
. In contrast, the interconversion rates for EmrE-S64V in the drug-free state are much 
slower. The rate is estimated to be ~0.5 s
-1
 across the pH range from 5.2 to 7.4. 
Collectively, these interconversion rates comparisons support the hypothesis that hydration 
around the TM3 kink regions may affect the rate of conformational interconversion. This is 
illustrated in the cartoon model in Fig 4.5 E. During the conformational interconversion, the two 
monomers in the asymmetric dimer of EmrE swap conformations. In particular, the TM3 from 
monomer A is straightened from the kinked state while the other TM3 from monomer B 
becomes kinked. When the 64 position of TM3 is mutated from the polar serine residue to 
nonpolar valine, the region around TM3 kink region is more dehydrated which effectively 
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increases the energetic barrier of helix kinking and unkinking by changing the local dielectric 
constant. This could be reasoned from both a thermodynamic and kinetic point of view. A 
nonpolar mutation would increase the strength of hydrogen bonding
33
, therefore lowering the 
free energy of the ground state. Meanwhile, this nonpolar mutation would increase the effective 
dielectric constant making exposing of polar groups during kinking and unkinking of helices 
kinetically more difficult. 
E14 pKa fine-tuning by hydration The pH titration of the drug-free state of S64V-EmrE reveal 
another interesting insight into the transport process. As previously discussed, WT EmrE is very 
sensitive to pH in the absence of drug. The two active site E14 residues in the antiparallel 
asymmetric homodimer have pKa values of 7.0 ± 0.1 and 8.2 ± 0.3
20
, and the rate of open-in to 
open-out exchange varies from ~220 s
-1
 to ~40 s
-1
 between pH 5 and 9.5
34
. Unlike WT EmrE, the 
interconversion for drug-free S64V-EmrE is very slow (~0.5 s
-1
), with two sets of peaks visible 
in TROSY-HSQC spectra over the entire pH range studied (4.8 - 10.5), and is independent of pH 
from 5.2 to 7.4. Solvent exchange prevents the acquisition of meaningful ZZ-exchange data at 
higher pH for S64V due to the long mixing times required to monitor the slow exchange process 
(the faster exchange rate of WT EmrE allows shorter mixing times to be used and ZZ-exchange 
data can be acquired up to pH 8.5). This dramatically different behavior was intriguing, 
particularly in light of the questions regarding how EmrE couples proton import to drug efflux 
given our recent findings that contradict the long-standing single-site alternating access for 
coupled antiport. Our recent discoveries of asymmetric protonation of EmrE
20
, its ability to 
interconvert between open-in and open-out in multiple different protonation states
20
 and the 
ability to simultaneously bind drug and proton (unpublished) are all inconsistent with traditional 





 transport using rates measured for microscopic steps within the transport cycle, but 
this naturally leads to another question: if proton coupling is achieved by careful tuning of the 
proton and drug transport halves of the transport cycle, how does EmrE harness the proton-
motive-force to actively pump such diverse substrates, particularly since we know that the 
kinetics of the open-in to open-out exchange process varies over several orders of magnitude for 
the substrate transport side of the cycle? 
We hypothesize that hydration provides the key, linking both substrate and proton transport by 
tuning both the conformational interconversion rate and the pKa of the critical E14 residue. 
Changing hydration patterns can affect pKa values and protein functions as demonstrated in 
several other cases
35-43
. We therefore predicted that reduced hydration of the transport pore in 
S64V-EmrE should further upshift the pKa values of the two Glu14 residues. 
This is indeed the case and is immediately obvious from the TROSY-HSQC spectra at several 
pH values (Fig. 4.6). The peaks of drug-free S64V-EmrE shift only slightly below pH 8, in stark 
contrast to WT EmrE
20
. With the use of ether-linked DHPC, we were able to collect spectra up to 
pH 10.8. At pH values higher than 8.6, significant number of peaks, especially those that are 
exposed to the solvent, disappear as a result of increased amide exchange. But it is very obvious 
from the residues that remain visible that two sets of peaks remain. From the curved pattern as 
the peaks shift across the spectrum with pH, there are at least two protonation events. I fit the 
chemical shifts as a function of pH using both a single pKa and double pKa model
20
. The double 
pKa model clearly gives better fits to the data, as was also observed in WT
20
. The fitted two pKa 
values, 8.6 ± 0.1 and 9.3 ± 0.2, are both at least one pH unit higher compared to WT EmrE. This 
not only supports the idea that hydration in the binding site is reduced as a result of the S64 






Fig. 4.6 pH titration of EmrE-S64V in drug-free state reveals a link between hydration and fine-tuning of E14 pKa 
value which is critical for energetic coupling in the transport cycle. A. TROSY-HSQC spectra at pH 5.9, 6.8, and 
7.8. Colors: pH 5.9, magenta; pH 6.8, red; pH 7.8, lime; pH 8.6, bright blue. B. Regions of spectra from pH titration 
show movements of peaks as the pH is increased. Upper figure, an enlarged glycine region; lower figure, a region 
including Ala10. Colors: pH 5.9, magenta; pH 6.4, pink; pH 6.8, red; pH 7.1, orange; pH 7.4, yellow; pH 7.8, lime; 
pH 8.1, green; pH 8.4, cyan; pH 8.6, bright blue; pH 9.0, navy; pH 9.3, lavender; pH 9.6, purple; pH 10.2, brown; 
pH 10.5, grey. C. Fitting of chemical shifts as a function of pH to a single pKa (dotted lines) and two pKa values 
(solid lines). Peaks are not assigned. The two pKa model fits better to the experimental data and gives 8.6 ± 0.1 and 
9.3± 0.2 while the single pKa model gives 8.6 ± 0.1. As a comparison, the two pKa model fitting for WT
20
 give 7.0 ± 




TM kinking central to interconversion As the number of membrane protein structures grows, it 
is clear that kinked helices are more common than initially expected, and TM helix kinks are 
usually found at sites of functional importance. Kinks commonly occur at Gly or Pro 
residues
2,3,5,6
 and may provide the correct functional groups and geometry for ligand 
coordination, or create hinge points for functionally important conformational changes required 
by many membrane protein functions. Such functions include moving molecules or transducing 
signals across the hydrophobic membrane barrier: transporters must alternately open to either 
side of the membrane, GPCRs must transfer information from one side of membrane to the 
other
44
, and ion channels must open and close in response to signals
45
.  
In the case of EmrE, substantive evidence points to the importance of the TM3 kink in the 
transport process
7,9-11,46
. Here, I show directly the importance of the TM3 kink for 
conformational exchange between open-in and open-out by demonstrating that mutation of S64 
leads to almost three orders of magnitude differences in the interconversion rate. For example, 
the glycine at position 64 increases the interconversion rate to > 100 s
-1
, consistent with 
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The role of hydration in helix kinking thus interconversion By comparing interconversion rates 
of different EmrE mutants and WT EmrE bound to different drugs, we identified a common 
theme that size and hydrophobicity of the amino acid side chain or substrate correlated with the 
conformational exchange rate. Thermodynamic characterization of substrate binding revealed 
enthalpy-entropy compensation, leading to the hypothesis that hydration around the TM3 kink 
may be important for substrate interaction, and perhaps also helix kinking and conformational 
interconversion of EmrE. As the residue at position 64 (or the substrate) gets bigger and more 
hydrophobic, the interconversion between open-in and open-out slows down, although this effect 
eventually plateaus. This suggests that there may be a shared dehydration process around the 
TM3 kink resulting from a combination of protein and ligand factors.  
Helix kinking within the hydrophobic environment of the membrane is generally unfavorable 
unless water or other proteins interactions can stabilize the broken backbone hydrogen bonding 
partners and lower the energetic barrier of exposing helix dipoles within bilayer. Residue 64 in 
WT EmrE is serine. Serine residues in helices can stabilize a TM helix kink since the side-chain 
hydroxyl group can hydrogen bond with the carbonyl group of the i - 4 residue
48-50
. However, 
mutation of S64 to alanine increases the interconversion rate, suggesting that hydrogen bonding 
potential is not a critical factor. Based on the observed pattern of effects across both mutant and 
ligand, neither hydrogen bonding potential nor the presence of polar groups are critical for rapid 
conformational exchange, supporting the more general hydration model. 
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Furthermore, the effect of S64 mutation on conformational exchange rate is even more dramatic 
in the drug-free state where the mutation is the sole perturbation, as expected from the proposed 
dehydration model. While WT EmrE in the absence of drug interconverts between open-in and 
open-out at rates between ~30 s
-1
 to > 200 s
-1 
in a pH-dependent manner. EmrE-S64V has a 
conformational exchange rate of ~0.5 s
-1
 near neutral pH in the absence of drug substrates.  
The hydration concept explains most of the experimental data, but it is clearly not the only factor 
affecting interconversion. S64L does not fit the trend of decreased conformational exchange with 
increasing side-chain size and hydrophobicity. Instead, the interconversion rate of TPP
+
-bound 
EmrE-S64L is significantly faster even than TPP
+
-bound EmrE-S64A. We hypothesize that 
leucine is large enough that it does not fit well in the tightly packed region of the TM3 hinge 
where it interfaces with the substrate binding pocket. The interconversion rate of drug-free 
EmrE-S64L is 1.2 ± 0.2 s
-1
, similar to drug-free EmrE-S64V and much slower than TPP
+
-bound 
EmrE-S64L. Thus S64L is more consistent with the overall pattern in the absence of substrate, 
suggesting that the binding site of EmrE, although plastic, still has limited space. Perhaps similar 




. This is also 
suggested by the global peak shifts observed between the drug-free and substrate-bound states of 
EmrE-S64V. 
Hydration as a unifying factor in transport In addition to the importance for TM3 kinking and 
open-in to open-out conformational exchange of EmrE, hydration could also influence the 
energetics of first solvent shell within the transport pore, affecting the pKa of titratable residues 
important for proton-coupled transport. The various kinetic steps, e.g. drug-off rate and 
interconversion rate, in multidrug transport by EmrE vary several orders of magnitude
11
 and pKa 
shifts upon drug binding will affect the efficiency of proton-coupled transport within our new 
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kinetic model for EmrE transport. The simultaneous effect of altered hydration within the 
transport pore on the rate of TM3 kinking and the pKa of E14 suggests a new model for how 
EmrE achieves proton-coupled transport of various drugs with different sizes, shapes, and 
charges. 
To date, studies of EmrE structure and dynamics have all been performed in symmetric 
environments. Yet, in vivo, the membrane asymmetry brought by the negative-inside membrane 
potential could be a defining feature affecting the kinetics and thermodynamics of multiple steps 
in the transport cycle. Hydration within the transport pore will also influence movement of 
charged residues within the pore across the membrane potential as the barrier switches from one 
side of the transport pore to the other. As a result, hydration may be an important unifying factor 
to simultaneously fine-tune multiple steps in the transport cycle and achieve efficient proton-
coupled transport.  
 
Conclusion 
In this chapter, I presented experimental data supporting the hypothesis that the TM3 kink in 
EmrE is crucial for conformation interconversion and transport activity. The perturbations of 
position 64 in TM3 dramatically changed the interconversion rate by over three orders of 
magnitude. Combined with the ligand perturbation series, this suggest that hydration within the 
transport pore may fine-tune the interconversion rate. In addition, these changes are also linked 
to more than 1 unit change of pKa values of E14, suggesting hydration may provide a key link 
between substrate binding site and the TM3 kink important for open-in to open-out exchange, as 
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Chapter 5: Asymmetric C-termini of EmrE 
Abstract 
EmrE, a small multidrug resistance transporter, is a model system for studying the transport 
process. Sequence conservation and prior NMR data suggest that the C-termini of EmrE may be 
functionally important. Unfortunately, currently available structures of EmrE lack information 
about the C-termini. Here we use the highly conserved C-terminal His110 residue as a reporter to 
probe the chemical environment of the C-termini in EmrE. Our results show that His110 from 
the two monomers within the asymmetric dimer have different upshifted pKa values and dynamic 
behaviors. These results reveal that the C-termini of the two monomers are not just flexible, 
water exposed tails but interact with the rest of the asymmetric dimer, providing the first insight 
into the structure and environment of the highly conserved C-terminal histidine. 
 
Introduction 
The C-terminal residue of EmrE, His110, is highly conserved,
1-3
 suggesting that it may be 
functionally important. Other residues conserved to this degree have been shown to be critical to 
function: Tyr60 and Trp63 (substrate recognition), Gly97 (dimerization), and Gly65 and Gly67 
(transmembrane helix 3 hinge). However, the role of His110 remains ambiguous. One potential 
role of His110 is in determining the membrane topology of EmrE due to its partial positive 
charge. EmrE has very low charge bias, consistent with its dual topology in the membrane, and 
addition of a single positively charged residue or multiple histidines to the C-terminus has been 
shown to alter the topology of the entire protein.
4
 However, the contribution of His110 to net 
charge bias does not sufficiently explain its conservation as the C-terminal amino acid in many 
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SMR family members since most of the other charged residues in EmrE are not highly as 
conserved. This suggests that His110 may have an additional function.  
A high resolution structure of EmrE could provide hypotheses for the role of His110. 
Unfortunately, the conformational plasticity that enables EmrE to transport diverse substrates 
also makes it a very challenging system for high resolution structural studies.
5
 As a result, there 




 structures available with no structural 
information on the C-terminal tail. Terminal regions of proteins are frequently missing from 
crystal structures due to their dynamic nature, and NMR is an ideal technique for studying 
flexible regions elusive to traditional structural approaches. Interestingly, the NMR spectra of 
EmrE suggest that the C-terminal region may have a unique structure or environment.
8
 The 
residues in this region, including 104-108, have very unique chemical shifts that are not typical 




Furthermore, the NMR spectra of EmrE in complex with different substrates show that the 
chemical shifts of residues 105, 106, and 108 from the C-terminal tail of one monomer in the 
homodimer are very sensitive to the identity of bound substrates while the residues in the tail of 
the other monomer are nearly insensitive to the bound substrate.
8
 Without direct structural data it 
is difficult to understand this stark asymmetry. However, considering the orientation and position 
of the fourth transmembrane helix in the best available structures, it is possible that the C-
terminus on the open side of the antiparallel dimer might extend into the substrate binding site 
while the C-terminal tail located on the closed side would be relatively isolated from the rest of 
the protein. Taken together, the experimental data available to date suggest that the C-terminus 
may have a functional role based on its high conservation and sensitivity to substrate identity.  
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To better understand the potential function of the C-terminal tail and conserved terminal 
histidine residue, we performed an NMR pH titration of the His110 side chains. These 
experiments probe the pKa and dynamics of the highly conserved His110 and provide additional 
insight into the environment of the C-terminus of EmrE. Histidine side chains can exist in two 
neutral tautomeric states (ε and δ) and one charged state (+). Studies of model compounds have 
established a set of characteristic 
15
N histidine chemical shifts for each of these states (Figure 
S1).
10-14
 The protonated and deprotonated nitrogen atoms in either of the two neutral forms have 
chemical shifts of 167.5 ppm and 249.5 ppm and the two nitrogen atoms in the charged state 
resonate at 174 and 178 ppm. The chemical shifts of histidine side chains are readily recorded, 
even in large membrane protein systems such as EmrE, using HMBC experiments where the 








N. Rapid exchange 
between the different states of the histidine side chain, as commonly observed in aqueous 
solution
14,15
, leads to 
15
N chemical shifts that are a population-weighted average of all species 
present. 
15
N chemical shifts of the histidine side chain as a function of pH can be analyzed to 
determine the pKa value as well as the tautomerization equilibrium constant, KT =[δ]/[ε].
13
 By 
comparing the pKa and KT values with those of model compounds in water (pKa of 6.2 and KT of 
0.25),
13
 we can get insight into the chemical environment surrounding the histidine side chains. 
 
Materials and Methods 
Protein purification and sample preparation 
The pET15b vector expresses EmrE with a N-terminal hexhistidine tag that can be removed by 
thrombin cleavage to leave three extra N-terminal residues (GSH).
7
 EmrE was overexpressed, 





 Briefly, BL21-DE3 cells containing EmrE expression plasmid were grown in M9 
minimal media. 
15













ISOGRO (Sigma Isotec), and one generic multivitamin per liter. EmrE overexpression was 
induced with 0.33 mM IPTG at an OD600 of ~1.0 at 17 ˚C for ~16 hours. His-tagged EmrE was 
purified in n-Decyl-β-D-maltopyranoside (Anatrace) via Ni-affinity chromatography and the tag 
was removed by thrombin cleavage. The tag-less EmrE was then subject to size exclusion 





N HMBC NMR spectroscopy 
All NMR experiments were performed on a 700 MHz Varian NMR spectrometer equipped with 
an HCN room temperature probe. 
15
N labeled NMR samples in DMPC/DHPC bicelles (100 
DMPC lipids per EmrE dimer) containing 1.2-1.5 mM EmrE (monomer concentration) and 2 
mM TPP
+
 were buffered by 20 mM acetate, 50 mM MOPS, and 50 mM bicine. NMR samples 
also contained 10% D2O, 0.05% NaN3. DSS (4,4-dimethyl-4-silapentane-1-sulfonic acid) was 
used for 
1
H chemical shift referencing and 
15
N chemical shifts were indirectly referenced.  
Sample pH was adjusted using a pH electrode calibrated at the same temperature and was 
measured again after each NMR experiment to account for any pH drift. pH drift during 2D 
NMR experiments was only observed for titration points above pH 8 and the average pH value 






N HMBC spectra of TPP
+
-bound EmrE were recorded from pH 5.1 to pH 







become antiphase was set to 22.8 ms so that magnetizations from 
1
JNH couplings are refocused.
10
 
In the HMBC experiment, magnetizations start from non-labile carbon protons (Hε1 and Hδ2) 






N atoms (Nε2 and Nδ1) in histidine side chains. So, for 
each histidine residue in a unique environment, there are two 
1
H and two 
15
N chemical shifts 










N TROSY HSQC experiments 
Four separate uniformly deuterated, 
15
N labeled NMR samples were prepared as described 
above. Samples contained 0.6-0.8 mM EmrE monomer as well as 20 mM NaCl, 0.05% NaN3, 
10% D2O, 2 mM TCEP, 2 mM TPP
+
, and 2 mM DSS and were buffered by 100 mM MOPS, 100 





N TROSY HSQC spectra were collected on each sample with a 700 
MHz Varian Inova spectrometer at 35°C. Following sample acquisition, the pH was checked 
again to confirm pH stability and the pH reported are averages of the pre-run and post-run pH 
measurements. To assess paramagnetic relaxation effects, 0.5 mM MnCl2 was added to each 
sample
17-19
 and another, identical, spectrum was collected in the same manner. 
Spectra processing 
All spectra were processed with NMRPipe
20







N HMBC spectra 
Histidine side chains exist in equilibrium between the charged state (+) and two neutral states (δ 
and ε) where the two neutral states are in a tautomeric equilibrium. The protonation equilibrium 
constant Ka is given by [δ+ε][H
+
]/[+], while the tautomerization constant KT is given by [δ]/[ε]. 
The recorded 
15
N chemical shifts of histidine side chains contain a wealth of information about 
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 (Fig. 5.1). In the charged state (+), both nitrogen atoms of histidine side 
chains have chemical shifts at around 176 ppm; this is an α+ type nitrogen. In the neutral states 
(δ and ε), protonated nitrogen atoms (Nε2 for ε state and Nδ1 for δ state) have α type chemical 
shifts of 167.5 ppm while unprotonated nitrogen atoms (Nδ1 for ε state and Nε2 for δ state) have 
β type chemical shifts at around 249.5 ppm. So at the low pH limit where the histidine is in the 
charged state (+), the spectra from HMBC experiments will have four peaks with an α+ type 
nitrogen chemical shift for both 
15
N atoms of a model compound.
13
 At the high pH limit, if there 
is a preference for ε or δ, there will be both α and β types of chemical shifts and the downfield 
peaks will correspond to β type nitrogens (Nδ1 or Nε2 for ε or δ preferences, respectively). If 
there are both ε and δ states at the high pH limit, the measured chemical shifts will be 
population-weighted averages of both states, since solvent exchange is fast in most 
occasions.
14,15
 At intermediate pH, the chemical shifts will be population-weighted averages of 









N HMBC peak patterns expected for different states of a model histidine side chain. 
 
Determination of pKa and KT values from pH titration spectra 





shifts at various pH values are fit to the modified Henderson-Hasselbalch equation, 
𝐶𝑆𝑜𝑏𝑠 = 𝐶𝑆ℎ𝑖𝑔ℎ ×
1
1+10(𝑝𝐾𝑎−𝑝𝐻)




where CSobs is the observed chemical shift. The chemical shifts at extreme low and high pH are 
represented by CSlow and CShigh respectively. CShigh is the population-weighted average of the 
15
N 
chemical shifts of both neutral states. 
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using typical chemical shifts of model compounds as reference values (167.5 ppm for α type and 






The measured chemical shifts for both Nδ1 and Nε2 at different pH values for each residue were 
fit using equation (1) with a single pKa parameter. The residue-specific KT constants were then 
estimated from equations (2) and (3).  
 
Results and discussion 




N HMBC spectra from pH 5.1 to 8.8 for TPP
+
-bound EmrE in 
DMPC/DHPC isotropic bicelles (q = 0.33). For the construct we use in our experiments, there 
are three additional residues remaining at the N-terminus after thrombin cleavage: GSH.
7
 The N-
terminal His-1 residue serves as a convenient internal control in this study. Since there are two 
His residues per monomer and two monomers per asymmetric EmrE dimer, we expect to see a 
maximum of four sets of peaks, assuming each histidine has only one major conformational 
state. Each set will in turn be composed of at most four peaks since the magnetization can start 




J to Nδ1 and Nε2. Fewer peaks may be 
observed due to weaker 
3
J coupling and/or dynamic exchange on an intermediate timescale. The 
resonance assignments for His110 and His-1 were made by performing a similar set of pH 
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titrations for a mutant with His-1 replaced by alanine (His-1Ala EmrE). Assignment to individual 
monomers could not be made since His110 is preceded by Pro109, which precludes through-
bond assignment methods, so the A, B designations for the two monomers within the dimer are 
arbitrary throughout this chapter. 
Across the pH range studied, both N-terminal His-1 residues behave like model compounds and 
there is little difference between the two His-1 residues in either chemical shift or dynamic 
behavior (Fig. 5.2). At pH 5.10, there are four peaks for each His-1 residue (connected with grey 
lines), and the two upfield peaks from both His-1 residues have degenerate chemical shifts 
suggesting they are experiencing very similar chemical environments. As the pH increases, the 
proportion of histidine side chains in the neutral states will increase, causing the 
15
N chemical 
shifts of all four peaks to move downfield. The Nδ1 peaks will move faster as long as the ε state 
is the preferred neutral state, as observed here. At around neutral pH, the two upfield peaks for 
the two His-1 residues remain very close. Meanwhile, both lower-right peaks (Nδ1-Hδ2) 
disappear possibly as a result of increased protonation equilibria in the context of an already 
small 
3
J coupling. The downfield movement of peaks continues as the pH increases and plateaus 
above pH 8. Note that as the chemical shift differences between the Nδ1 and Nε2 peaks become 
really large at pH 8.8, the peak widths increase significantly, implying that the exchange between 









N HMBC spectra of TPP
+
-bound WT EmrE collected on a Varian 700 MHz spectrometer with a room 
temperature probe at varying pH: (A) pH 5.10 ± 0.02, (B) pH 6.87 ± 0.00, and (C) pH 8.80 ± 0.15. Peaks belonging 
to His110/His-1 are labeled and connected with red/grey dotted lines. The assignments of Nε2 and Nδ1 peaks were 
made by comparing relative peak intensities. A, B designations are arbitrary here. Assignments were made by 






















B: Nε2-Hε1 B: Nε2-Hδ2
B: Nδ1-Hε1












To quantitatively estimate the pKa and KT values, we fitted the 
15
N chemical shifts over this pH 
range using equations 1-3 as described in more detail in methods section.
13
 The modified 







)   (1) 
where CSobs is the observed chemical shift and CSlow and CShigh represent the extreme chemical 
shifts at high and low pH, respectively. Since CShigh is the population weighted average of the 
15




      (2) 
with reference to the ε or δ state chemical shifts of model compounds. The tautomeric 




        (3). 
As can be seen in Fig. 5.3, the titration series for the two His-1 residues can be well fit. The same 
results are obtained whether the two nitrogens are analyzed individually or simultaneously for 
each residue. Here we only report the globally fit parameters. The two His-1 residues have pKa 
values of 6.26 ± 0.03 and 6.13 ± 0.03, similar to model compounds (pKa of 6.2). The KT values 
for the two His-1 residues are 0.37 and 0.33, which are also close to model compounds (KT of 
0.25). Both these quantitative results and the qualitative behavior of the His-1 peaks in the NMR 
spectra suggest that the twoHis-1 residues exist in a symmetric, water-exposed environment, 





Fig. 5.3 Histidine 
15
N chemical shifts as a function of pH (symbols) together with the global fitting (lines). Error 
bars represent standard errors and are shown only when they are larger than the size of the symbol. 
 
Based on recorded chemical shifts and titration behaviors, the two C-terminal His110 residues 
are clearly different from His-1 and are also different from each other (Fig. 5.2).  At pH 5.10, the 
two His110 residues have more downfield chemical shifts compared to His-1, implying the 
His110 residues are more protonated and have higher pKa values. As the pH increases, 
differences between the two His110 residues become apparent. At pH 6.87, His110B still has 
four visible peaks that are distinct from the other three histidines, while His110A only has two 
upfield peaks visible with chemical shifts more similar to His-1. His110A completely disappears 
from the spectra above neutral pH. Given that the chemical shift difference between protonated 
and unprotonated 
15
N corresponds to 5.7 kHz on a 700 MHz spectrometer, this signal loss 












well above the pKa, His110B differs dramatically from His-1 and the spectral pattern indicates 
that His110B not only has a significantly upshifted pKa but also a different KT value. The fitted 
pKa value for His110B is 6.82 ± 0.01, and the KT value is ~0.69 (Fig. 5.3), which indicates more 
of the δ species is present in the neutral state than is typical for a model compound. The 
stabilization of the δ species could come from H-bonding with any electronegative group of the 
system, including the C-terminal carboxylate group.
13
 For His110A, as a result of a lack of data 
above pH 6.87, the pKa cannot be confidently determined but is estimated to be in the range of 
6.3-6.6, somewhat upshifted from model compounds. Nevertheless, both the titration behaviors 
and the fitted pKa values demonstrate that the two C-terminal His110 residues are experiencing 
different environments. 
To get more insight into the environment surrounding His110, we measured solvent accessibility 
of the backbone of TPP
+
-bound EmrE by determining the paramagnetic relaxation enhancement 








N TROSY-HSQC across the same pH range (Fig. 
5.4). At pH 5.2 and 6.0, the His110 signals for both monomers are not fully relaxed by the 
paramagnetic ion, indicating they are partially protected from the solvent. However, at pH 7.1 
and 8.4, the signals become fully relaxed. While it is not possible to deduce what interaction 
could be protecting the backbone from solvent at low pH, this data does begin to provide an 
explanation for the shifted pKa values: the protonated state appears to be interacting with either 
the membrane or the protein itself. Since this technique is monitoring the backbone and is not 
sensitive enough to detect minor differences, it is not surprising that we cannot see a distinction 









N TROSY-HSQC of TPP
+
-bound EmrE. At each pH, spectra were collected first 






In summary, we have made use of the 
15
N chemical shifts of histidine side chains to probe the 
chemical environments of the two C-termini of TPP
+
-bound EmrE. Our data reveal that the two 
His110 residues each display a distinct dynamic behavior and both have upshifted pKa values. 
This is in sharp contrast with the two N-terminal His-1 residues which behave very similarly to 
each other as well as to model compounds. These findings suggest that the two C-termini of the 
asymmetric EmrE dimer are not simply disordered, solvent-exposed tails, a claim which is 
further supported by the observed protection from a soluble paramagnetic agent at low pH. 
However, if the upshifted pKa values were simply due to stabilization of the protonated state by a 
relatively non-specific interaction with the water-lipid interface, a phenomenon not uncommon 
to histidines in membrane environments,
22
 one would expect the two histidines to display very 
similar dynamic profiles and pKa values. Likewise, a simple interaction with the carboxyl groups 
of each terminus should also have similar effects on both His110. The fact that the dynamics of 
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the two C-termini are distinct suggests that interaction with the asymmetric EmrE dimer is likely 
contributing to the unique environments of the two His110 residues. Although the data presented 
here cannot speak directly to the nature of this interaction, it is interesting to note that the 
timescale of dynamics which is the likely cause of signal loss from one of the two His110 is not 
in the open-in to open-out conformational exchange regime
9
 but is of the same order of 
magnitude as loop dynamics and ring flipping. Interaction with either the loops or one of the 
several aromatic residues in the substrate binding site or even the substrate itself could lead to 
dynamics on this timescale. As it has previously been observed that residues in one of the C-
termini are sensitive to the drug identity,
8
 it is tempting to speculate that one of the C-termini 
may interact with the protein near the drug binding site. However, further information, such as a 
high-resolution structure, will be needed to test this possibility. Nonetheless, this research begins 
to reveal the environment of the highly conserved C-terminal histidine and highlights the need to 
consider the role of the C-termini in future mechanistic studies. 
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Chapter 6: Conclusion and Future Direction 
My doctoral thesis focuses on a small multidrug resistance transporter, EmrE, which is a model 
system for secondary active transporters. Despite decades of intensive studies, mechanistic 
understanding about how EmrE couples proton import and drug export remains rather 
immature
1
. This results from, to a large extent, a lack of atomic descriptions for different 
structural states in the transport cycle and the dynamic processes linking these structures states, 
since transport is inherently a dynamic process. Therefore, my thesis studies both structure and 
dynamics of EmrE in order to provide mechanistic insights about proton-coupled multidrug 
transport. This is enabled by the use of NMR, a powerful technique to study structure and 
dynamics simultaneously with atomic resolution. Complemented by other techniques, our 
structure and dynamics studies have made good progresses towards building a higher-resolution 
structure of EmrE and understanding the physicochemical basis underlying conformational 
interconversion central to transport processes in general. 
We have overcome several challenges involved in NMR structure determination of EmrE. The 
conformational interconversion, where EmrE exchanges between open-in and open-out, is 
constantly ongoing. This makes the long-sought high-resolution structure of EmrE extremely 
challenging to obtain by any structural approach. The relatively small size and constant dynamics 
of EmrE make NMR the best approach for structural studies. Yet, the conformational 
interconversion still poses significant problems for NMR structure determination which can only 
tolerate certain levels of dynamics.  Therefore, through collaborative screening, we set out to 
find potential dynamics mutants and identified EmrE-S64V as a slow dynamics mutant suitable 
for structural studies. Though this mutant makes NMR structure determination of EmrE possible, 
this is still a highly challenging project. Current NMR structures are mostly for molecules with 
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molecular-weight less than 25 kDa, and NMR structure determination of helical membrane 
proteins are further complicated by signal overlap and limited tertiary restraints. Therefore, 
considering the asymmetric dimer of EmrE has eight unique transmembrane helices, we have 
made very good progress by assigning most of backbone and side chain methyl resonances. 
These resonance assignments were only possible using the most cutting-edge technologies 
including sparse sampling and specific labeling designed for large and challenging systems. This 
is aided by our novel approach making use of the often challenging factors inherent to EmrE, e.g. 
the use of ZZ-exchange data from conformational interconversion to assign pairs of amide 
resonances in combination with backbone-walk data. Our assignment processes and mechanistic 
insights are also coupled. This is reflected by the convergent chain assignment within the 
asymmetric EmrE dimer aided by the pH titration data and concurrent realization that 
protonation of E14 is asymmetric, causing systematic peak shifts in monomer B, which is 
mechanistically relevant to proton coupling. Another beneficial factor in our assignment process 
is the combination of experiment and theory through integration of our NMR data with 
collaborative modeling studies. These modeling studies not only provided good starting points 
for structure-based assignment, but also provided feedback on inconsistencies for refinement 
during the iterative assignment process.   
There are very limited NMR studies for systems as complicated as this one. My research helps 
push the boundary on several frontiers of biomolecular NMR structure and dynamics of 
asymmetric, dynamic assemblies and integral membrane proteins, which will be of general 
interest to the broader biomolecular NMR community. I have tried various labeling strategies for 
side chain resonance assignment designed for large systems with mixed success, and these 
lessons will help future studies of membrane proteins, which have some distinct challenging 
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features from large soluble protein complexes. For example, our strategy of initiating more 
extensive side chain resonance assignment from methyl groups is broadly applicable for 
membrane protein systems. However, due to the hydrophobic environment of membrane 
proteins, a significant portion of methyl groups face lipids and therefore are not as valuable as 
those in soluble proteins, necessitating an approach that goes beyond backbone and methyl 
groups. Nevertheless, the technological advances in ILV methyl labeling provide starting point to 
bootstrap assignment of other side chain resonances. Methyl groups also provide tertiary 
restraints for initial definition of helix packing. 
Our methyl assignments are only possible because we have collected high quality methyl-
detected out-and-back and amide-detected spectra. It is worth to point out that the high quality of 
these methyl assignment experiments based on COSY was unexpected considering the general 
pessimistic impression from the literature. This case encourages future research into this COSY-
transfer route for large systems.  
My work also highlights the importance of aromatic residues in NMR structure determination of 
membrane proteins, which should be seriously considered for future studies. This is in part 
because of the limited amount of restraints that can be collected for helical membrane proteins 
due to requirements for deuteration and the fact that many methyl groups face lipids and do not 
contribute long-range restraints for 3D structure determination. This is especially important 
considering the controversies involved in several membrane protein NMR structures. Despite the 
challenges involved, side chain restraints from methyl and aromatic groups should both be 
considered for future NMR structure determination of helical membrane proteins. 
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Our large sets of NOESY spectra on samples with various labeling schemes will provide a 
reasonable number of distance restraints. In addition, these distance restraints are further 
complemented with orientational restraints from high precision RDCs measured using strained-
gel induced alignment.  
To finish the structure, iterative assignment of the large sets of NOESY spectra must be 
completed along with structural calculation. Structure calculations will be aided by the starting 
structures from our collaborative modeling studies and the newly implemented implicit 
membrane model within Xplor-NIH
2
. Ideally, more extensive testing of the resulting final 
structures in explicit membrane environment should be performed by continued collaboration. 
These modeling studies certainly will continue to offer insights and generate hypotheses for 
future experimentation. For example, further NMR and MD research will likely contribute key 
insights to the proton-coupling mechanism in atomic detail.  How is the proton transferred within 
the pore and how is this affected by the presence of drug? How does the C-terminus from 
monomer A behave with different protonation states of both E14 and H110 residues? What is the 
hydration pattern within the pore under different conditions? How will the presence of 
membrane potential change the system?  
The EmrE-S64V mutant also makes structural studies of drug-free states possible. The next 
structure(s) that could be pursued should be the proton-bound state(s). After the first structure is 
solved, it will be much easier to solve related structures. The help from modeling will reduce the 
barrier even more as well. These structures will provide further information about the structural 
basis of the proton-coupling mechanism, e.g. how EmrE avoids leaking proton even though it 
can interconvert between open-in and open-out in multiple protonation states.  
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Our dynamic studies of the series of S64 mutants, following the identification of EmrE-S64V, 
demonstrate for the first time that mutations near the TM3 kink in EmrE alter rates of global 
conformational exchanges dramatically. This provides experimental confirmation of the 
hypothesis that the TM3 kink of EmrE serves a as hinge enabling global conformational 
transition needed for transport activity. In addition, our characterization of the mutant series 
together with the ligand series suggest a very interesting trend that the interconversion rate 
decreases with increasing hydrophobicity within the pore. These data pointed me to the 
importance of hydration for enabling the helix kinking and unkinking required for 
conformational interconversion. What is more, the hydration concept could be more broadly 
involved in the overall transport process. The S64V mutation not only changes the rate of 
interconversion, but also perturbs the pKa values of E14 by more than one pH unit, suggesting 
that hydration could fine tune important steps involving proton transport as well. This 
observation makes hydration a unifying factor to understand the proton coupling mechanism of 
EmrE. Furthermore, the multidrug transport activity of EmrE has several rate-limiting steps, e.g. 
drug off-rate and interconversion rate, which are orders of magnitude different for different 
ligands. Hydration could provide the underlying explanation for how EmrE achieves proton-
coupled multidrug transport with such different kinetics of individual steps by simultaneously 
tuning the pKa shift upon substrate binding. 
Further structural characterization of the TM3 kink under a variety of conditions, combining 
different substrates and kink region mutants will help develop future mechanistic insights into 
the interconversion process. To get more precise measurements of helix orientation information 
for EmrE, oriented solid-state NMR experiments such as PISEMA should be performed for 





In order to get direct information about the hydration pattern around kink region, NMR H/D 
experiments and molecular dynamics simulation for several mutants should be performed. Also 
ITC experiment in H2O vs D2O
4-6
 would directly probe the solvent reorganization contribution 
involved when comparing different mutants. Neutron scattering
7
 might also be helpful if changes 
in hydration are significant enough. Interpretation of these experimental data will benefit greatly 
from accompanying simulations that provide atomic structural and kinetic models of hydration 
within the transport pore. 
More studies are needed to further explore the effect of ligands and mutants on the pKa of E14. 
This will develop a deeper understanding of coupling between E14 protonation and TM3 helix 
kinking.  
Most of our dynamic studies so-far focus on the interconversion, and therefore fall into the ms-s 
timescale regime. Studies that extend beyond these timescales are needed to fully link the 
dynamics to the function. For example, ps-ns dynamics of different mutants could provide 
further information about how slight changes in local flexibility in the TM3 hinge are linked to 
the rates of global conformational change. Also further CPMG dynamic studies on the sub-
millisecond dynamics of the C-terminus (Chapter 5) may provide further insight into its role in 
transport.   
I have aimed to understand the workings of this biological machinery by reconstituting it in vitro. 
While necessary for initial characterization, this provides a very simplified environment. In the 
case of EmrE, the symmetric bilayer environment in particular is an oversimplification. Adding 
another layer of complexity by introducing membrane asymmetry and membrane potential will 
be necessary to truly understand how EmrE works.  
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In conclusion, our structural and dynamic studies on EmrE not only push boundaries on many 
frontiers of NMR, but also demonstrate the usefulness as well as the need to employ the new 
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